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Testing is widely acknowledged to be a useful and necessary secondary tool of Human 
Immunodeficiency Virus (HIV) prevention. It is the method by which to identify people who 
are living with the virus, so that their behaviour may be modified and medical condition 
treated in order to prevent further infection. Unfortunately, many persons in South Africa 
(SA) remain undiagnosed and therefore unaware of their HIV-positive status. 
 
This thesis explores why it is necessary to test for HIV in SA, where the incidence of the 
virus remains the highest in the world. Voluntary Counselling and Testing (VCT) or the „opt-
in‟ approach has been adopted as the norm or „sine qua non‟. The efficacy of this method will 
be interrogated and shortcomings identified. The most notable is that few people in SA 
undergo an HIV test in order to learn their status. When they do, it is often late in the 
progression of opportunistic infections, requiring hospitalisation that increases pressure on an 
already over-stretched healthcare system. Reasons for the poor uptake of VCT are explained, 
including pervasive stigma and deficiencies in leadership of SA‟s HIV and AIDS response. 
 
The expansion of testing is a proposed response to the challenge of persons remaining 
undiagnosed, and includes the acceleration of „opt-out‟ or routine HIV testing (RHT) among 
SA‟s high prevalence population. This model offers an HIV test routinely to persons 
attending government healthcare settings with an illness or for a routine check-up. Although 
the provider initiates the test, consent is necessary in order to proceed and there is an option 
to decline. 
 
While the key focus of this thesis is routine HIV testing, other approaches are explored in 
brief, including mandatory testing, mobile clinics and wellness screening. The thesis argues 
that if SA is to achieve the HIV and AIDS and STI National Strategic Plan (NSP) target of 
increasing the number of adults who have ever had a test to 70 percent by 2011, new 
approaches to testing, and especially opt-out, will need to be explored and more widely 
adopted. 
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GLOSSARY OF TERMS 
 
AIDS   Acquired Immune Deficiency Syndrome 
ARK   Absolute Return for Kids 
ART   Antiretroviral Therapy 
ARV   Antiretroviral 
AZT   Azidothymidine (a type of antiretroviral drug) 
BCG   Bacillus Calmette-Guérin (tuberculosis vaccine) 
BONELA  Botswana Network on Ethics, Law and HIV/AIDS 
CDC   Centers for Disease Control and Prevention (USA) 
DBSA   The Development Bank of South Africa 
DoH   Department of Health 
DTHF   Desmond Tutu HIV Foundation 
EIA   Enzyme Immunoassay 
HAART  Highly Active Anti-Retroviral Therapy 
HIV   Human Immunodeficiency Virus 
HIVCTR  HIV Counselling, Testing and Referral 
HSRC   Human Sciences Research Council 
HSV   Herpes Simplex Virus 
IIDMM  Institute of Infectious Diseases and Molecular Medicine 
KBP   Knowledge, Behaviour and Practice 
MCC   Medicines Control Council 
MMWR  Morbidity & Mortality Weekly Report (of the CDC) 
MSF   Médecins Sans Frontières 
MSM   Men who have Sex with Men 
MTCT  Mother-To-Child Transmission 
MRC   Medical Research Council 
NACA   National AIDS Coordinating Agency (Botswana) 
NSP   National Strategic Plan 
OI   Opportunistic Infection 
PCP   Pneumocystis Carinii Pneumonia 
PHC   Primary Health Care 
PITC   Provider-Initiated Testing and Counselling 












PMTCT  Prevention of Mother-To-Child Transmission 
PrEP   Pre-Exposure Prophylaxis 
PSA   Prostate Specific Antigen 
RHT   Routine HIV Testing 
RRT   Routinely Recommended Testing 
RTC   Routine Testing and Counselling 
SA   South Africa 
STI   Sexually Transmitted Infection 
SWS   Student Wellness Service (at UCT) 
TAC   Treatment Action Campaign 
TB   Tuberculosis (Pulmonary) 
UCT   University of Cape Town 
UNAIDS  Joint United Nations Programme on HIV/AIDS 
UNDESA  United Nations Department of Economic and Social Affairs 
VCT   Voluntary Counselling and Testing 














Over 5.2 million people are living with HIV in South Africa (SA) (Shisana et al., 2009). The 
UNAIDS (2007) notes the “localized reduction in prevalence in specific countries” has not 
been observed in SA. HIV prevalence among females aged 25 to 29 persists at a high level of 
33 percent, and prevalence levels have risen among adults aged 15 to 49 between 2002 and 
2008 in most provinces, the highest of which is KwaZulu-Natal at 10.1 percent (Shisana et al., 
2009). Otherwise, a levelling out of prevalence can be attributed partly to the continual deaths 
from AIDS that disguise the real rate of new infections (Butler, 2009). 
 
According to Dr Venter (2008), president of the Southern African HIV Clinicians Society, 
despite the fact that the prevention of mother-to-child transmission (MTCT) is being 
promoted, there are 70,000 paediatric infections per annum in SA. Presently, fewer than 80 
percent of pregnant women are tested for HIV, suggesting an urgency to accelerate the 
promotion of prevention of mother-to-child transmission (PMTCT) (Day et al., 2009). At 
least there has been a decline in prevalence among children, attributed mostly to the success 
of programmes in the Western Cape to prevent MTCT (Shisana et al., 2009). 
 
Additionally, in spite of an antiretroviral (ARV) roll-out since 2002, people continue to die of 
AIDS; 3.7 million since 2003, with almost 722,000 in 2007 alone (Momberg, 2008). The 
Treatment Action Campaign (TAC), an NGO advocating for the rights of people living with 
HIV/AIDS (PLWHA), estimates that whilst there are approximately 700,000 people taking 
ARVs in SA‟s public health sector, at least double this number need treatment. Additionally, 
five people become infected with HIV for every two who start taking ARVs (Beresford, 
2008). UNAIDS (2007) blames infections with HIV and deaths from AIDS “mostly” on 
“inadequate access to HIV prevention and treatment services”.  
 
The above statistics clearly demonstrate prevention efforts are failing SA, a country where the 
HIV epidemic is bound up with contextual complexities: extreme inequalities of wealth and 
opportunity, a large rural populace distanced from better resourced urban centres and an 
under-resourced and transforming health service guided by the primary health care (PHC) 
approach. Whiteside (2008) states “The one critical thing is prevention. It‟s common sense. If 
we can prevent infection, we don‟t have to treat it. We have failed hopelessly”. The epidemic 












In view of the above, perhaps it is time to take a fresh look at prevention efforts. Vaccines are 
a long way off and a microbicide has to date proved elusive (Nelson, 2007; Shelton, 2007; 
Microbicides Development Programme, 2009). The use of diaphragms and lubricant gel by 
women has not proved effective against the virus (Padian et al., 2007), pre-exposure 
prevention or PrEP utilising ARVs as a prevention measure is still in the trial phase (Hillier, 
2008) and suppression of Herpes Simplex Virus 2 (HSV-2), a sexually transmitted infection 
(STI), has not worked (Watson-Jones et al., 2008). 
 
Male circumcision has been found to reduce the possibility of transmission of HIV from 
women to men by up to 60 percent (Auvert et al., 2005; Williams et al., 2006; Halperin & 
Epstein, 2007; Weiss et al., 2008; Klauser et al., 2008), but there is no national policy on 
circumcision to date (Shelton, 2007). Also, Sithole et al. (2009) indicate there is ambiguity in 
the term „circumcision‟, since Zulus only remove the tissue under the penis glans and not the 
foreskin („ukugweda‟ or partial circumcision). They therefore caution against wide promotion 
until more evidence comes to light of effectiveness and acceptability, and indicate public 
health messages have to be adapted to suit different cultural contexts. 
 
Condoms have been widely distributed and extensively promoted through social marketing 
campaigns in SA by government and non-government actors alike, with a 14-fold increase in 
distribution between 1997 and 2004, yet HIV incidence has failed to significantly decline. 
This could be attributed in part to the failure of 90 percent of people to use condoms at every 
sexual encounter (Venter, 2008; Halperin & Epstein, 2007; Shelton, 2007). On a more 
positive note, there was an increase from 57 percent in 2002 to 87 percent in 2008 of men 
aged 15 to 24 using condoms and from 46 to 73 percent among the same age group of 
women. Condom use doubled for men aged 25 to 49 and tripled among the same age group 
of women (Shisana et al., 2009). The essential promotion of condoms must be combined with 
other prevention tools. 
 
Messaging (public service announcements and techniques of social marketing) has an 
important part to play in the HIV prevention effort. This includes messages that tackle 
structural causes or „drivers‟, such as: stigmatising behaviours (Chesney & Smith, 1999); 
concurrent sexual partnerships (Epstein, 2007), which have increased by nearly 10 percent 












inequalities, highlighted in a Medical Research Council (MRC) Policy Brief on rape and HIV 
by Jewkes et al. (2009).  
 
More messaging is needed to reach high-risk groups, including men who have sex with men 
(MSM), recreational drug users, heavy drinkers, women aged 20 to 34 and men aged 25 to 
49. Messaging is at least reaching the younger population of SA: 90 percent of young people 
report having heard at least one programme, compared with only 38 percent of persons over 
50 years. However, despite this messaging, HIV prevention knowledge has declined at 
national level among the 15 to 49 year age group (Shisana et al., 2009). 
 
Then there is the secondary prevention tool of HIV testing, which will be the central focus of 
this thesis. It is a screening process that determines the HIV status of a person. Such testing 
was introduced in the 1980s as Voluntary Counselling and Testing (VCT), where the onus is 
on the individual to test. Whilst other tests, like those for diabetes or cancer, are offered and 
undertaken unless the client expressly refuses, HIV has been afforded a special status, with 
an emphasis on the „three Cs‟ of consent, counselling and confidentiality, argued in terms of 
the protection of human rights. This came about largely because of early associations 
between the epidemic and the stigmatised community of gay men on the west coast of the 
USA, the mainly sexual mode of transmission and the link between incurable HIV, disease 
and death (Herek & Glunt, 1988; St. Lawrence et al., 1990). The stigma of the disease 
extended to the testing site, affecting the willingness of persons to go for a test (Myers et al., 
1993; Stall et al., 1996; Chesney & Smith, 1999).  
 
„AIDS exceptionalism‟ was born out of the lack of treatment availability, the perceived 
inability of healthcare facilities to protect confidentiality and concerns that MSM would be 
further discriminated against (Bayer & Fairchild, 2006; Jaffe, 2009). The thesis will argue 
that there is no longer any need for exceptionalisation of the testing process and that there 
may be more effective ways in which to test persons for HIV than through VCT. 
 
To what extent is testing in itself a useful and necessary tool of HIV prevention? There are 
those who argue that, given the stigmatisation of the disease, letting people know they are 
positive years before they are at risk of becoming sick may be an act of cruelty. There are 
also concerns that rapid testing kits can produce false positive results (where a person who 












person. However, the rapid test in common use in SA has a high sensitivity (accuracy in 
detecting HIV-positivity) and specificity (accuracy in detecting HIV-negativity), with only a 
tiny percent of false positives. 
 
Chapter One of this thesis highlights the overwhelming individual and societal benefits of 
testing, which far outweigh any concerns. It will seek to demonstrate that testing is an 
important aspect of prevention and care and hence an appropriate response to the HIV 
epidemic in a situation of limited healthcare resources. 
 
When people are ignorant of their status, others may be unknowingly infected, particularly as 
symptoms are not necessarily in evidence. Knowledge of status affords persons the 
opportunity to reduce onward transmission. There is strong evidence (Weinhardt et al., 1999; 
Crepaz & Marks, 2002; Marks et al., 2005; Bartlett & Mayer, 2006; Delpierre et al., 2007) that 
people who test positive change their behaviour to engage in safer sex. However, evidence is 
inconclusive that people testing HIV-negative adopt more responsible sexual behaviours 
(Higgins et al., 1991; Fleming et al., 2000). Paradoxically, viewing HIV as a manageable 
medical condition may make some people less careful regarding their sexual behaviour. Thus 
as a prevention tool, testing has great value, but limitations must be recognised. 
 
Notwithstanding, there are considerable benefits associated with testing, principally of 
„enabling‟ treatment for HIV – knowledge of one‟s HIV-positive status is essential to be able 
to receive treatment and to live healthier for longer. Initiation of ARVs means less rapid 
progression to the onset of opportunistic infections (OIs) and a reduction in the exorbitant 
cost of hospital treatment. Additionally, knowledge of a woman‟s HIV-positive status will 
enable the appropriate action to prevent transmission to a child. 
 
Chapter Two interrogates VCT and questions its efficacy. It argues that a method accessible to 
only a few cannot identify sufficient HIV-positive persons. When HIV is identified, it is often 
too late in the infection stage for effective treatment, which makes this method outmoded. 
 
The HIV and AIDS and STI Strategic Plan for South Africa (NSP) 2007-2011 aims to 
increase by 60 percent by 2010 and 70 percent by 2011 the number of adults who have ever 
had an HIV test, and the number of adults testing in a year by 22 percent for 2010 and 25 












explored and more widely adopted. Chapter Three discusses the feasibility of expanding the 
introduction of opt-out or routine HIV testing (RHT), rather than continuing to focus on the 
opt-in or VCT approach. Opt-out testing is an offer of a test, given to a person attending a 
government health facility with an illness or for a routine health check (Cockcroft et al., 
2007). This is an approach that has been widely adopted in Botswana, which is analysed as a 
case study. It is acknowledged by the author that Botswana is a country with a different 
history and economic climate to SA, and a much smaller population. However, the 
experience of one of SA‟s high prevalence neighbours remains relevant and its lessons are 
important. The value of the opt-out approach is evaluated in terms of uptake, early detection 
of HIV and general awareness of one‟s HIV-positive status.  
 
Chapter Four – Research Methodology – explains the reasoning behind the utilisation of a 
literature review and an interview approach. The thesis is based on in-depth interviews with 
key informants in the epidemic, who have long experience of its challenges in the Western 
Cape. They are Physician Dr Linda-Gail Bekker, Constitutional Court Justice Edwin 
Cameron, Economist Dr Susan Cleary, Public Health Specialist Dr David Coetzee, 
Epidemiologist Dr Rodney Ehrlich, HIV Clinician Dr Ashraf Grimwood, Pharmacologist 
Gary Maartens, and University of Cape Town (UCT) Human Resource specialists, Margie 
Tainton and Ashley Taylor. 
 
All informants were selected for their academic excellence, skills of interpretation, peer-
reviewed research output, and wide knowledge concerning health economics, epidemiology 
or other field of expertise – and the esteem in which they are held. In selecting persons for 
interview, I did not succeed in identifying any active opponents to the pursuit of other forms 
of testing for HIV. This is not to suggest they do not exist. Chapter Four provides more 
comprehensive information on each respondent, which will serve to elucidate why they were 
selected for interview. 
 
The Chapter Five discussion seeks to investigate whether there is a need for a change in 
testing methodology, as the landscape has altered inexorably over more than 27 years of an 
HIV response. As Supreme Court Judge and AIDS activist Edwin Cameron (2005) states, 
“Where treatment is available, signs increasingly suggest that the exceptionalisation of HIV 
infection in the healthcare setting may be impeding its effective management”. With the 












progressively being regarded like any other chronic, manageable condition, and no longer a 
death sentence.  
 
Dr Linda-Gail Bekker (2008), Principal Investigator at the Desmond Tutu HIV Foundation 
(DTHF), argues testing needs to be demystified. There is a need “to call it what it is… it‟s a 
test. Like you get your blood pressure tested or your glucose tested, you need to get tested”. 
„Normalising‟ testing will reduce its association with stigma and discrimination. The chapter 
enquires whether RHT, reviewed as effectively implemented in Botswana, could be 
introduced more widely in SA.  
 
The Conclusion draws together the challenges, emphasising the need to adopt a number of 
different approaches to screening, in a leadership-driven, concerted effort, so that SA is able to 
provide an appropriate and effective response to testing for HIV and achieve anything close to 

















The prevailing view among international and SA HIV and AIDS experts is that testing is 
critically important both for prevention and effective treatment. They argue that if an 
individual knows her/his HIV status s/he is more likely to adopt safer sex behaviours; more 
likely to start leading a healthy life-style if s/he is not doing so already; and will be able to 
start treatment as soon as it is needed, rather than when s/he is already very ill – the case with 
many people. Late treatment increases the costs of treatment exponentially because the 
person often needs intensive care in hospital for a long period; it means the person is 
infectious longer than need be and it leads to many unnecessary and costly deaths among 
those for whom late treatment fails.  
 
There are, however, important resource implications of earlier testing, coupled with 
significant social barriers. If testing is encouraged, it should ideally be accompanied by a 
CD4 test to determine the level of infection and monitor its progress. This is not possible in 
many testing settings. Earlier testing also implies support for those living with a positive 
diagnosis, including psychological support. There are two recognised periods of major 
depression linked to a positive diagnosis: following diagnosis and when treatment is 
recommended. However, psychological services simply are not available for most of SA‟s 
population. The question of stigma is also critical. While this may not be as pronounced as it 
was in the early years of the epidemic, people still fear it. It is one reason why some people 




Learning one‟s HIV-positive status is a life-changing experience, which can be traumatic. It 
means adopting new behaviours and starting a lifetime regimen of drugs. Furthermore, fear of 
social ostracism and internal self-stigmatisation make the positive diagnosis an ongoing source 
of anguish for many. Grace Sedio, a public figure living with HIV in Botswana, suggests 














Ehrlich (2007) describes anecdotal evidence that suggests unrelated ill-health symptoms and 
anxieties are likely to develop and Grimwood (2007) highlights the issues of fear and 
denialism, and the complexities around stigma and trying to manage a grief reaction. Gary 
Maartens (2007), one of Cape Town‟s most experienced HIV/AIDS physicians, suggests there 
are particular situations, including heavy depression or suicidal risk, when a health practitioner 
should defer sharing news of an HIV-positive test result. 
 
Lack of symptoms 
 
Healthcare providers in SA are increasingly trained to be aware of possible symptoms of acute 
HIV infection, including dry coughs, recurring fever and night sweats, headaches, unexplained 
fatigue, nausea, diarrhoea, enlarged lymph nodes and rapid weight loss. Rodney Ehrlich 
(2007) argues each generation of trainee doctors coming through will know more and be better 
geared to diagnose HIV infection. He says if someone presents with a chronic cough, “the first 
three things we look for are tuberculosis, tuberculosis and tuberculosis”. 
 
However, a prolonged asymptomatic period after infection means people living with HIV 
may have no symptoms for ten years or more post-infection. Acute HIV infection is difficult 
to diagnose, as flu-like symptoms (listed above) are easily mistaken for another viral 
infection, often disappearing after a week to a month. In research by Pincus et al. (2003), 
patients with acute HIV infection could not be “reliably distinguished” from HIV-negative 
patients through identification of symptoms or physical findings. 
 
Waiting for symptoms is ill-advised as they typically occur late, when the viral load is high, 
the CD4 cell count low and OIs occur. This is particularly pertinent to the testing of pregnant 
women, when there is another life at stake (Maartens, 2007). Coetzee (2007), a public health 
expert, describes people coming to his clinics with a CD4 count of well below 200 cells/mm3 
who have never had a single symptom – they only learn their status because they are pregnant. 
Likewise, people who present with an STI, but are otherwise well, learn they are HIV-positive 
only because they are tested. Ultimately, the only way to know the status of individuals (and 














Reduced risk of transmission 
 
So, testing is necessary in order to confirm a person‟s HIV status. However, does evidence 
support the assertion that testing results in a reduction in viral transmission?  
 
Research is inconclusive (and opinion is divided) regarding whether a negative test result 
encourages sexual behaviour change (Shelton, 2007). Evidence (anecdotal and otherwise) 
suggests short term behaviour modification at most. Higgins et al. (1991) reviewed 50 
research studies in published abstracts, journal articles and presentations that analysed the 
effects of HIV testing and counselling on risk behaviours. They focused on homosexual men, 
intravenous drug users, pregnant women and other heterosexuals. They found scant evidence 
to suggest people who test negative would practice safer sex. Indeed the studies suggested 
high-risk behaviours may be adopted if people perceive treatment to be effective and therefore 
worry less about becoming HIV-positive. Fleming et al. (2000) point to anecdotal evidence 
amongst gay men supporting this theory.  
 
Holbrooke and Furman (2004) do suggest if people test negative there is an incentive for them to 
start practicing safer sex. Ehrlich (2007) also speculates a negative test result may make a 
difference: “I‟ve been so worried, I‟ve been paralysed, and now that I know I‟m negative it 
gives me a bit of control back”. There is some evidence to support these remarks. Surveying 
clients at a Milwaukee Health Department STD clinic in the USA, DiFranceisco et al. (2005) 
used regression analysis to show that people engaged in safer sex directly after testing for 
HIV. They identified a “brief surge” in condom use amongst women and men recently 
counselled and tested for HIV, whether HIV-positive or negative, which lasted a few months. 
Bekker (2008) suggests more research is needed to ascertain whether sexual behaviour changes 
when people test HIV-negative, asserting that her own prevention trials have seen behaviour 
modification.  
 
Research evidence is much stronger in support of the theory that knowledge of one‟s HIV-
positive status reduces the likelihood of viral transmission. Weinhardt et al. (1999) report 
increased condom use and a reduction in unprotected sex among HIV-positive participants and 
HIV-serodiscordant couples after counselling and testing. They conclude testing and 
counselling is therefore an effective means of secondary prevention when people test HIV-












are infected with HIV reduce their practice of high-risk sex by about half. Rates of STI 
transmission are also much reduced. However, this study did not analyse behaviour change 
over time and unprotected sexual behaviour may be under-reported. Bartlett (Bartlett & Mayer, 
2006) argues that those who test positive make an effort to prevent infecting others and manage 
to reduce transmission even more substantially (four-fold from nine percent to two percent), 
while Crepaz and Marks (2002) assert that widespread HIV testing brings a reduction or 
elimination of transmission behaviours of between 50 and 66 percent. 
 
Finally, the South African Department of Health (2007) draws on several studies when it 
asserts that there is an increase in prevention behaviours and risk reduction strategies among 
people who know their HIV-positive status. 
 
Pre- and post ARV availability 
 
Despite a dramatic increase in the provision of ARVs in sub-Saharan Africa (UNAIDS, 
2006), and an expanding roll-out in SA, many people are still without access. The TAC 
(2009) notes that “at least double the current number of people who are on ARVs need 
treatment urgently to survive”. Even the Health Minister Aaron Motsoaledi admits that the 
targets of the NSP are over ambitious in a country with funding shortfalls, a shortage of 
health professionals and an overburdened health sector – only 700,000 people are receiving 
ARVs, a half of the NSP target (PlusNews, 2009). Testing does bring with it the expectation 
of treatment and Alcorn & Smart (2006) argue that the benefit of learning one‟s status is 
questionable without it. It is therefore pertinent to ask whether testing should be promoted 
when ARVs are not universally available. 
 
It is important for services to be able to provide prevention support for people testing negative 
and for people to be referred for care who are HIV-positive – even if they are not yet ready for 
highly active antiretroviral therapy (HAART) (HIV & AIDS Treatment in Practice, 2007). A 
healthcare provider may assist a patient by providing valuable information and encouraging 
responsible life choices, such as practicing safe sex, avoiding re-infection and transmitting the 
virus, eating properly, quitting smoking and managing stress (Coetzee, 2007). 
 
Additionally, non-ARV medical interventions are available for PLWHA, in order to prolong 












reduction in the frequency of Pneumocystis Carinii Pneumonia (PCP), an OI related to HIV 
(Clumeck, 1995). Farham (2007) confirms that a person with PCP can receive regular 
prophylaxis of co-trimoxazole or Bactrim® or pentamidine, all of which have a treatment 
success rate of 70 to 80 percent. Using a model-based approach, Walensky et al. (2006) found 
that “compared with survival associated with untreated HIV disease, per-person survival 
increased 0.26 years (3.1 months) with PCP prophylaxis alone”. There are also a number of 
prophylaxes available for the treatment of, for example, candidiasis or thrush and toxoplasma 
encephalitis (Farham, 2007). 
 
Co-trimoxazole or Bactrim® has been used in clinical settings in SA for about 10 years to 
treat OIs (Maartens, 2007; Grimwood, 2007; Ehrlich, 2007). It is described by Maartens 
(2007) as “a very good and cheap prophylactic antibiotic that reduces death rate by about 45 
percent for advanced patients”. Stating that it is not worth testing at public health level for 
something that cannot be treated, he asserts that HIV does not fall into this category, as good 
interventions are available that decrease morbidity and mortality, even with severe immune 
impairment. 
 
A number of commentators describe the important shift in perception from AIDS as a death 
sentence to management of HIV as a chronic condition, with the advent of ARVs. Mark 
Heywood (2005) of the AIDS Law Project describes a shift from “an invariably fatal” disease 
and Cameron (2006a; 2007) asserts that even in resource-poor settings, the prognosis is 
“excellent” once a person is on a constant and appropriate regimen. Dr Banu Khan, the 
National Coordinator of the National AIDS Coordinating Agency (NACA) in Botswana, 
argues that it is necessary to approach HIV differently from the early years of HIV incidence, 
since free treatment is now available (BONELA, 2003). 
 
WHO‟s 3 by 5 initiative and declaration to work towards universal access to ARVs (Heywood, 
2005), the commitment to treatment roll-out by the Global Fund and PEPFAR, and Millennium 
Development Goal commitments (UNDESA, 2007) speak to making ARVs available to all. 
For this to happen, and to ensure people do not remain undiagnosed and die of AIDS, testing for 
HIV needs to be considerably expanded (Hamill et al., 2007). WHO/UNAIDS (2007) describe a 













From the public health and clinical perspective it is critical to diagnose HIV early, before the 
onset of OIs (De Cock & Johnson, 1998). Later identification may result in irreversible 
immunological damage and death (Sanders et al., 2005; Delpierre et al., 2007). As ARVs are 
increasingly available in resource-poor settings, Bendavid et al. (2008) highlight the value of 
CD4 cell count monitoring and early treatment in terms of cost-saving and health benefits 
through preventing hospitalization and prolonging life. Grimwood (2007) and Bekker (2008) 
believe in the importance of getting one‟s CD4 cell count taken immediately after testing 
positive for HIV, in order to learn whether it is necessary to start on ARVs. There is also an 
opportunity for counselling provision, and for ongoing discussions and questions. 
 
The considerable value of ARV provision after testing for HIV is recognised by a number of 
commentators in terms of life-years gained. Bartlett (Bartlett & Mayer, 2006) argues that it 
would be difficult to match HIV in terms of treatment dividends. Walensky et al. (2006) 
record the 3 million life years being saved since the advent of treatment in 1989. Venter 
(2007) asserts that 30 life years can be earned if a person starts in good time on an ARV 
regimen. Sanders et al. (2005) estimate, with use of a model, the increase in life years of 1.52 
when HIV is identified and treated early (HAART was initiated at CD4 count of 350 




In resource-constrained SA the debate is ongoing about when a person should begin to take 
ARVs. Reasons given for delaying treatment include “the toxicity and inconvenience of drugs, 
fear of rapid resistance accumulation, and likelihood of further improvements in antiretroviral 
drugs” (Phillips et al., 2007). 
 
Now that there is a greater understanding of the effect of drug regimens on the body, 
commentators argue the benefits of starting on an HIV regimen when the CD4 cell count is at 
350 cells/mm3 (Phillips et al., 2007). SA‟s soon-to-be-revised National Antiretroviral 
Treatment Guidelines recommend treatment initiation when the CD4 count falls between 350 
and 200 cells/mm3 or when there is an AIDS-defining condition. However, when ARVs are 












immunodeficient. Loubiere et al. (2008) indicate that it is more cost-effective to provide 
HAART than to treat HIV-related OIs. 
 
The SA government in December 2009 (South African Government Information, 2009) 
announced its intention to increase the CD4 threshold for starting on ART to 350 cells/mm3 
for all people co-infected with HIV and TB, and all pregnant HIV-positive women. 
Additionally, all children under one year of age will receive treatment if they test positive, 
regardless of their CD4 cell count. Such policy changes, state Cleary and McIntyre (2009), 
have major resource implications. 
 
Decreased infectivity from taking ARVs 
 
The test for HIV has public health value as the viral load is lowered when ARVs are initiated 
early, which reduces infectivity and therefore transmission (Fleming et al., 2000; Sanders et al., 
2005; Bartlett & Mayer, 2006; Delpierre et al., 2007; Jaffe, 2009). Transmission to sexual 
partners is reduced by 20 percent. Hence, Pincus et al. (2003) describe the identification of 
patients with acute HIV as having a “public health benefit that cancer screening does not”. Even 
if a person continues to engage in unsafe sex, the chance of transmission to their partner is 
reduced with a lower viral load (Quinn et al., 2000). 
 
Financial costs of early testing 
 
The cynical could argue that when so many of the population living with HIV are 
unemployed, their deaths are not a loss to the SA economy. However, there is a moral 
imperative to make ARVs available, and to find the resources in order to do so. Additionally, 
Bell et al. (2003) studied the long-term economic implications of AIDS in SA, concluding 
that there would be a substantial loss of the government‟s tax base and a complete economic 
collapse without a suitable response to the epidemic; the perception that it is only the poor 
who become infected by HIV is challenged by industrial data and the professions of teaching 
and healthcare (PulseTrack Healthcare Consulting, 2003). 
 
It has been found to be cost effective to increase the number of people who know their HIV-












hospitalisation and treatment for OIs (Rotheram-Borus et al., 2006). Persons with very low 
CD4 cell counts who start ART are more likely to need costly in-patient treatment and to die, 
which is not economically viable (Chen et al., 2006; Bartlett & Mayer, 2006; Maartens, 2007), 
as persons are lost to the workforce and dependents are left without support – a further burden 
on the state in terms of welfare expenditure. 
 
There is of course an increased cost of ARV provision when more persons are identified as 
living with HIV. The HI virus can mutate, in which case the combination of ARV medicines 
initially administered (a first-line regimen) has to be changed to a different combination of 
ARVs (a second-line regimen). Cleary and McIntyre (2009) argue that first-line ART is 
preferable to second-line ART, as it is more efficient and allows all who need treatment to 
receive it at lower cost. They acknowledge that the provision of first and second-line ART 
has become a norm in SA and this status quo will not be overturned.  
 
The unsavoury choices if there is not affordability in SA‟s resource-poor health system are to 
ration HIV treatment, or scale down or cancel other interventions. If SA is to afford a 
universal ARV roll-out, the huge financial burden will have to be shared by global health 
initiatives.  
 
Reducing the impact of stigma 
 
It is important to encourage “supportive attitudes and practices within communities”, so that 
stigmatising of people – discriminating against and stereotyping – does not stop them from 
protecting the self and others, thereby hindering efforts at prevention (Crepaz & Marks, 2002). 
Cameron (2007) speaks of the internal stigma and fear that prevents people from knowing, or 
in the case of Dr Ian Phillips (former ANC member and activist) and Ronald Louw (former 
Professor of Law at the University of KwaZulu-Natal, human rights lawyer and activist), 
disclosing their status.  
 
In an open letter of condolence to the family of Phillips, the TAC urged people to test for HIV: 
“Finding out your status before your CD4 count drops below 200 or you develop serious OIs 
is the best way to ensure long-term survival with the disease”. If a large number of people 
know their status, there is more likely to be social pressure to reduce stigma. Likewise, the 














Whilst acknowledging the potentially psychologically harmful effects of learning about one‟s 
HIV-positive status, the empowering knowledge outweighs the negative impact, in that a 
person is able to make appropriate lifestyle choices and access life-giving and -enhancing 
treatment (Henn et al., 2006; Cameron, 2007; Maartens, 2007; Grimwood, 2007). Cameron 
(2006a) asserts, “One could even say it is within the duty of care to conduct a test – the 
alternative to death”. 
 
Transmission and therefore HIV incidence declines when PLWHA refrain from unprotected 
sex (Fleming et al., 2000; Crepaz & Marks, 2002; Marks et al, 2005 & 2006; Henn et al., 
2006; Delpierre et al., 2007; Ehrlich, 2007). OIs can be countered even without ARVs 
(Ehrlich, 2007). Where ARVs are available, if diagnosis occurs early before a person becomes 
ill and has to be hospitalised, a considerable cost is averted to the individual in terms of life-
years and the state in healthcare expenses. When engaging in unsafe sex, HIV-positive persons 
are less contagious as the viral load decreases with effective therapy (Kahn & Walker, 1998). 
 
UNAIDS (2004) is unequivocal regarding the importance of testing: “Among the 
interventions which play a pivotal role both in treatment and in prevention, HIV testing and 
counselling stands out as paramount”. Holbrooke and Furman (2004) add that the answer to 

















The HIV epidemic is not abating in SA, despite massive resources devoted to prevention 
through behaviour change initiatives and to testing for HIV. This poses the questions of what 
is being done wrong and what more could be done. As the focus of this paper is testing for 
HIV, the present state of testing in SA – utilization of the VCT approach – will be interrogated 
in order to identify its shortcomings and explore solutions to the challenges. 
 
The evolution of testing for HIV 
 
Testing for HIV has evolved in SA over time, in terms of the testing kits and therefore the 
methods utilised. Initially, a small sample of blood was taken from a person and was sent to a 
laboratory in an enzyme immunoassay (EIA) or ELISA test – the process from blood taking 
to results took up to two weeks and typically required two visits; the first for pre-test 
counselling and taking of blood and the second to receive the results and undergo post-test 
counselling and follow-up. This process was time-consuming, available to only a few and 
very costly. 
 
The rapid test for HIV was then introduced into SA, defined by the South African DoH (2006) 
as “a test used to determine a person‟s HIV antibodies in whole blood as well as in serum or 
plasma (by a finger prick) that takes about 10 to 30 minutes to perform”. An advantage of the 
rapid test is that results are available immediately, negating the need for a further visit. It has 
been found that if a return is necessitated, people fail to do so and are lost to the system. For 
example, a Kaiser Family Foundation (2006) survey reports that one in six people in the USA 
failed to return for their test results, when undergoing conventional testing with laboratory use. 
Bartlett et al. (2008) put this figure at up to a third of HIV-infected patients in the USA. On-
site rapid testing improved the coverage of persons receiving their results at clinics in 
Francistown, Botswana (Creek at al., 2007), and at two Ugandan hospitals (Wanyenze et al., 
2008). 
 
The rapid test also has the advantage of being “highly accurate”, making it more feasible to 












sensitivity (with few false-negative results) of current HIV tests, and false positives in low risk 
populations of only about 1 in 250,000 are applauded by Wynia (2006). The shortcoming of 
false positives could be due in part to lack of quality assurance and inadequate training of 
nursing and lay counsellor staff by government and NGOs, plus the lack of optimal conditions 
for storage (Maartens, 2007). At least all positive test results are confirmed in SA – allowing 
for the detection of false positives – with a conventional EIA and Western Blot test. 
 
Additionally, rapid testing costs are lower than laboratory processes (CDC, 2005), useful in 
SA‟s resource-poor setting, and the HIV test is (as the name implies) quick and non-invasive 
(Coetzee, 2007). It can be done in a variety of healthcare setting where laboratory facilities are 
unavailable, and non-laboratory personnel, such as clinical nurses and doctors, can administer 
the tests and share the results. Post-test counselling can happen immediately and persons can 
enter quickly into medical care. 
 
For the above reasons rapid testing for HIV has become the norm in SA. So, too, has a 
particular approach to testing become primary in SA - Voluntary Counselling and Testing 
(VCT). It tests those who proactively seek an HIV test, with no active encouragement from a 
healthcare provider. The South African Department of Health (2006) defines it as:  
 
“an HIV prevention and care intervention which gives the client a voluntary 
opportunity to be counselled in order to explore his or her HIV risk; to learn about his 
or her HIV status; and to learn about other HIV and AIDS-related services and how to 
modify their behaviour to reduce the risk of HIV infection”.  
 
All tests utilising VCT require the consent of the individual and also a process of pre- and 
post-test counselling, of anything up to 20 minutes in the case of a negative result and up to an 
hour in the case of a positive result. A definition of pre-test counselling is given by the South 
African Department of Health (2006): 
 
“A dialogue between a provider and a client with the aim of preparing and assisting a 
client to make an informed decision about taking an HIV test”… “a health provider 
should recommend HIV counselling to all clients on a routine basis to ensure that all 













Post-test counselling is described as: 
 
“a dialogue between a provider and a client with the aim of informing the client of 
his/her HIV test results and assisting the client to understand the implications of the 
results and facilitate access to appropriate services”. 
 
The value of pre-test counselling 
 
An emphasis on the word „voluntary‟ has resulted from the response to early calls for 
mandatory testing of high-risk groups, particularly the already stigmatised gay population of 
the West Coast of USA (Richter, 2006): the three Cs – (pre and post-test) counselling, 
(informed) consent and (test result) confidentiality – were prioritised as a response to the 
“pervasive stigma, demonization and criminalisation” of PLWHA and people at risk of 
infection (Csete, 2006). In an era when treatment for HIV in the form of ARVs was 
unavailable and when there was a huge amount of stigmatization and discrimination, pre- and 
post-test counselling with confidentiality and written consent were vital (Bekker, 2008). This 
vital, protected, human rights paradigm shielded people from discrimination, exposure, 
disclosure and compulsory testing (Cameron, 2007).  
 
Present-day advocates of the pre-test counselling component of VCT argue that it enables 
persons to be better equipped to cope with their status and will encourage them to adhere to an 
ARV regimen (Heywood, 2005). Others maintain that behavioural change will only result if 
there is adequate pre-test counselling, information and consent (Kenyon, 2005). This assertion 
is challenged by the findings of Weinhardt et al. (1999). Having reviewed the available 
literature, they conclude there is no difference in sexual behaviour for people testing negative 
after counselling than for those who never receive counselling. Citing the CDC‟s Project 
RESPECT, they suggest that “enhanced” counselling with a few sessions does result in greater 
use of condoms and less STIs. However, they admit to weaknesses in their review of the effect 
of counselling, as they could only draw on meagre documentation of the diverse range of 
counselling techniques and length and intensity of provision. 
 
There is a strong lobby arguing pre-test counselling has little value and is therefore redundant, 
particularly as the HIV landscape has changed considerably over nearly 30 years. The 












of association with the gay community are redundant, and persons are only dissuaded from 
being tested (Wynia, 2006; Cameron, 2007; Creek et al., 2007; Grimwood, 2007). Creek et al. 
(2007) indicate that people prefer not to engage in discussions on sexual behaviour and HIV 
risk that are of a highly personal nature. “It is time to abandon this ethnocentric Western 
rhetoric”, state Holbrooke and Furman (2004), “born in the 1980s in the United States under 
different circumstances that led to the „V‟ in VCT”. Venter (2007), a harsh critic of VCT, 
argues it has failed because people do not volunteer, and that “denial and illness have 
triumphed over knowledge, as the outmoded language of human rights is still in vogue”. 
 
The value of pre-test counselling for HIV continues to be hotly debated, as consensus has not 
yet been reached. There is clearly uncertainty regarding the extent that it impacts on the 




Too few people are testing for HIV in SA and persons are therefore living without knowledge 
of their status. The HSRC (Shisana et al., 2009) is encouraged that the percent of people who 
are aware of their status rose from 12 in 2005 to 25 in 2008, but still emphasizes the need to 
further improve the uptake of HIV testing. Awareness of status in 2008 among African 
females, the highest level of awareness, was only 36 percent, with awareness among MSM at 
27 percent and African males (aged 25 to 49) at 25 percent (Shisana et al., 2009). Men are a 
particular category who fail to test if not encouraged, even if they are aware of treatment 
availability (Richter, 2006). 
 
Ignorance of status is not unique to SA or other developing nations. The situation in rich 
countries is not much better, if the USA case is anything to go by. A study in six cities in the 
USA found 77 percent of a total of 573 young HIV-infected MSM did not know that they 
were infected (CDC, 2003, Janssen et al., 2007). In the USA more generally, the estimate of 
persons unaware of their HIV-positive status is 25 percent (CDC, 2003; Glynn & Rhodes, 
2005; Paltiel et al., 2005; Walensky et al., 2005a; Janssen et al., 2007). Fifty-four percent of 
new sexually transmitted HIV-1 infections originate from this 25 percent (Marks et al., 2006), 
indicating that persons unaware of their status are 3.5 times more likely to transmit the virus 













As VCT puts the burden of responsibility to test on the client, people who perceive themselves 
to be without risk will not get tested. This is problematic, as such people (for example, married 
or widowed persons) may actually be in a high-risk category. In a behavioural survey (Shisana 
et al., 2005), 66 percent of respondents thought they were probably or definitely not at risk of 
HIV infection and more than half of those who tested positive thought they were risk-free. The 
Kaiser Family Foundation (2006) reports that the lack of risk perception is the most common 
reason people in the USA fail to test for HIV, cited by 61 percent of people never tested. Glick 
(2005) asserts that “considerations from behavioural models and the available data suggest 
that as VCT coverage expands… potential uptake among those at highest risk is uncertain”. 
 
Although Richter (2006) describes the near impossibility in SA of being able to measure VCT 
impact and of knowing how many people are aware of their HIV status, the HSRC household 
survey figures of Shisana et al. (2009) are of concern. They reflect a low uptake of the client-
initiated process of VCT (Whiteside, 2008), which results in the failure of an appropriate 
treatment and prevention response (De Cock, 2005). 
 
Testing too late 
 
Early identification of HIV allows an appropriate treatment response, which suppresses the 
viral load and brings about a decline in infection (Pincus et al., 2003; Frieden et al., 2005). 
However, the reality is that people who test for HIV often do so late, resulting in a late 
diagnosis. “Current approaches to testing are inadequate”, state Sanders et al. (2005), as many 
people at risk are not tested, and HIV-positive people are identified with advanced disease. 
Wanyenze et al. (2006) similarly describe VCT as a “missed opportunity to identify and refer 
for care many seropositive individuals”, as people without “overt signs and symptoms” of 
AIDS are not offered an HIV test as readily as those who present with “overt complications”. 
 
A PLWHA in SA does not necessarily visit a health provider and therefore only discovers 
their status in the symptomatic phase, at which time ARVs are less beneficial (UNAIDS, 
2006). This is a problem particularly among men (Courtenay, 2000). Women are more likely 
to visit health providers, but many only learn of their positive status when they are pregnant. 
 
Infections of PLWHA go unnoticed by healthcare providers and others for years (Frieden et 












being diagnosed (Pincus et al., 2003) and are only treated when they have AIDS-defining 
conditions (CDC, 2006b). Paltiel et al. (2005) argue that with current HIV testing practices in 
high-risk populations, 29 percent of HIV-infected people remain undetected until the onset of 
an OI. Bassett et al. (2007) add that although patients come into contact with the health system 
in SA, they are not referred for testing and therefore remain undetected with the model of 
VCT. Increased mortality results, as almost half of newly identified cases have an AIDS 
defining condition within one year.  
 
In his work as a clinician, Venter (2007) sees people dying of AIDS because they do not 
discover their status in a timely manner, despite the relative availability in SA of a free HIV 
test and ARVs. He describes “treatment compromised” patients: “huge numbers of people 
tested when they are severely ill and the use of antiretroviral drugs is far more complex and 
less effective”. Zackie Achmat (Cheng, 2007), a leading SA AIDS activist, similarly describes 
“the biggest problem” as an overburdened healthcare system full of sick people who come too 




Particular elements of the testing process have made VCT less effectual than it should be, and 
have resulted in negative perceptions (Kalichman & Simbayi, 2003). There is an absence of 
task-shifting, which would allow (well-trained) lay-counsellors and not nurses to perform the 
test. De Cock (2005) criticises VCT as “onerous in time and counselling requirements”, which 
discourages attendance and means that fewer persons are tested. In Uganda, according to 
Wanyenze et al. (2006), citing the Uganda Demographic Health Survey (2000-2001), despite 
72 percent of women and 74 percent of men expressing a wish to test (a number due to rise 
with access to ARVs), only eight percent of females and 12 percent of males knew their status 
due to the inaccessibility of VCT. 
 
Young people will hesitate to go for a test for HIV if they think their guardians and others in 
their small community might learn of their use of such a facility. If known by healthcare 
providers, embarrassment may serve as a further deterrent. It is sometimes these same 
healthcare workers who stigmatise PLWHA and „judge‟ the young people utilising services 
(Steinberg, 2008). Health workers were identified as a source of stigma in Botswana, before 












Valdiserri (2002) and Gruskin et al. (2008) highlight the importance of healthcare workers 
who are non-judgmental about behaviours of their clients, in order to allay the fear of testing 
and to encourage people to be tested. Arguing that people at high risk may not test in a timely 
manner due to previous experience of negative attitudes of the healthcare system, Valdiserri 
(2002) concludes that it is the responsibility of public health practitioners “to work towards 
minimizing the negative health consequences of HIV and AIDS stigma”. For this to be 
guaranteed, healthcare workers would need to receive anti-stigma workshops and training in 
counselling skills. 
 
The impediment of stigma 
 
It is internal stigma that results in “paralysed inaction, postponement, delay, denial and death”, 
according to Cameron (2006b). Arguing that people do perceive the act of testing to be of 
value, Kalichman and Simbayi (2003) suggest people do not seek VCT due to social barriers 
to getting tested, particularly AIDS stigma. Chesney and Smith (1999), Kalichman and 
Simbayi (2003), UNAIDS (2004) and Richter (2006) also state that stigmatising beliefs 
prevent people from being tested for HIV. There is fear of the consequence of a positive 
diagnosis, discrimination and the disease-death association, and there is a lack of trust in the 
healthcare system, states Heidi van Rooyen (2007) of the HSRC. 
 
Observers have attributed the low uptake of VCT that occurred in Botswana after the 
introduction of ART in 2002 (and prior to the introduction of RHT) to HIV-related stigma. 
Wolfe et al. (2006) “found evidence of pervasive stigma in patterns of disclosure, social 
sequelae, and delays in HIV testing”. Ninety-four percent did not disclose to their community 
and 69 percent kept this information from their family. 
 
People will be reluctant to get tested for HIV if their condition or the test itself is stigmatised 
or if the perception is that PLWHA will be stigmatised. The more people test, the more normal 
the process becomes and the stigma will lessen. If testing were made easier, people may be 
pushed to overcome their hesitation. This may create “a bridge… to cross over the perilous 














The impact of fear 
 
It is unclear to what extent fear of learning one‟s status dissuades persons from being tested 
for HIV. Cameron (2006a) describes people who have “access to medication, support and the 
assurance of acceptance and non-discrimination – yet who are too fearful, too tardy, to have 
themselves tested”. Valdiserri (2002) highlights a number of studies showing people avoid 
HIV testing as they are fearful of the result and of others learning about their status. This was 
borne out in research conducted by Wolfe et al (2006) in Botswana. Weiser et al. (2006) 
similarly found 49 percent were prevented from testing by the fear of knowing their status and 
33 percent were fearful of having to change sexual practices on learning of an HIV-positive 
status. Additionally, women avoided testing because of the fear of having to wait in a small 
room for hours. 
 
Cameron (2005) asserts that the “fuss and bother” associated with the exceptionalism of VCT 
serves to frighten people who think they might be HIV-positive and inhibit their attendance at 
a testing site, constituting “a source of risk and harm”: he explains that it “reinforces their own 
conception of the exceptional, horrific and unacceptable nature of the infection”. As well as 
reinforcing their fears, the safeguards “accentuate also their inner disavowal of entitlement to 
betterment”, and cause people to describe their illness as something else. 
 
The high cost 
 
There is an inadequacy of cost-effectiveness data on VCT provision in sub-Saharan Africa, 
indicate Stanley et al. (2004), as it only includes select costs, models output data and focuses 
on insufficient time periods. Their analysis, however, concluded that costs were higher than 
expected, with staff costs dominating. 
 
Forsythe et al. (2002) explain that high cost VCT is not affordable in low-income countries, 
with tight health budgets, but also indicate research has not compared integrated and stand-
alone services. They suggest that integration into existing services would better integrate care 
















Although more persons are testing in SA than ever before (Shisana et al., 2009), there is still a 
considerable shortfall in the number voluntarily coming forward, and in those achieving early 
diagnosis. This is the reality at a time when VCT predominates, a testing process that has been 
under-utilised, and can only therefore be described as “partially successful” in terms of cost-
effectiveness (Maartens, 2007). Stigma, fear of disclosure and lack of accessibility have a part 
to play in this underutilisation (Grimwood, 2007). The VCT process is also human resource 
and time-intensive, largely due to the emphasis on pre-test counselling. There are some 
effective VCT programmes, confirmed by HIV & AIDS Treatment in Practice (2007), but 
“the coverage of these noble efforts is spotty at best”, and scale-up is restricted by the lack of 
capacity. These more successful efforts have been insufficiently replicated (Gruskin, 2005). 
 
Since VCT is not able to adequately identify people in SA who are living with HIV, and if it is 
our aim, reaffirmed by President Zuma in his World AIDS Day message (South African 
Government Information, 2009), to accelerate the number of people testing for HIV in SA, 
should we rather focus on the exploration of other testing methods? One such method, the 

















Social marketing campaigns, such as those of New Start, attempt to „sell‟ VCT to the SA 
public. Members of the public do buy into the „product‟ of an HIV test, but it is ultimately a 
waiting game – waiting for someone to consent to be tested. There has been a marked 
evolution in the HIV epidemic over the past 27-plus years, with ARVs now available but 
people still dying of AIDS. It is therefore appropriate to investigate new approaches that may 
result in greater numbers testing, in order “to put those who are newly-diagnosed in a position 
to better manage their HIV status and to enable them to access treatment when it is medically 
appropriate” (Richter, 2006). 
 
It is particularly in countries with high prevalence, argue Bassett et al. (2007), including SA, 
that new approaches are needed for the sake of both individual care and public good. This is 
essentially the application of public health principles to the epidemic, which, argue Frieden et 
al. (2005), will “prevent tens of thousands of people [in this country] from becoming infected 
with HIV in the next decade”. 
 
The focus of this chapter is the routine or opt-out approach that has been lauded by the CDC 
and implemented in Botswana with enthusiastic government support. 
 
Promotion of routine HIV testing 
 
Opt-out screening is defined by the CDC (2006a) as “performing an HIV test after notifying 
the patient 1) that the test will be performed and 2) that the patient may elect to decline or 
defer testing”.  
 
“Routine HIV testing means that when somebody attends a government health facility 
with some kind of illness or for a routine check-up, they are offered an HIV test. They 
have to give their consent to have the test and have the option of refusing. If they test 
positive, they are offered counselling and appropriate treatment as necessary” 













As early as 1993, the CDC recommended that hospitals and associated clinics in areas with 
high HIV prevalence offer HIV testing routinely to all patients aged 15-54 years (CDC, 2001). 
By 1998, De Cock & Johnson (1998) argued that it should be within the competency of all 
doctors to offer such a test. 
 
Del Rio et al. report in the MMWR (CDC, 2001) that few screening programmes had been 
implemented in hospitals and clinics with high prevalence by 2001, despite the 1993 
recommendations of the CDC. Concerned that newly diagnosed HIV infections had increased 
by 14 percent among MSM and 10 percent among heterosexuals between 1999 and 2001 in 25 
states in the USA, the CDC (2003) and US Department of Health and Human Services Agencies 
launched „Advancing HIV Prevention: New Strategies for a Changing Epidemic‟ in 2003. 
 
UNAIDS (2004) called for an increase in the promotion of RHT in clinical settings, 
emphasising from the outset the importance of a human rights approach and the respect for 
ethical principles (They argued for a non-consensual approach only if an urgent response was 
required and a patient was unconsciousness). RHT was particularly recommended in the 
settings of: a) STI clinics or elsewhere, with counselling dependent on status; b) prevention of 
MTCT; and c) clinical and community healthcare, with a higher prevalence of HIV and ART 
availability. 
 
As slow testing uptake continued, operational guidelines were formulated in 2006 by 
WHO/UNAIDS (2007) on provider-initiated testing and counselling in clinical settings, after 
consultation with a range of stakeholders. In response, Human Rights Watch (2007) asserted 
that “scaled up HIV treatment... is both a human right and public health imperative”, adding 
that “scaling up testing should not be an end in itself” but rather a means to ensure the 
adoption of behavioural changes and enhances prevention, treatment and care. 
 
CDC (2006c) at the end of 2006 recommended HIV screening for people aged 13 to 64 in all 
healthcare settings. The need for counselling would be the same as for other serious 
conditions, described by Bartlett et al. (2008) as “transmissible infections”: the idea was not to 
do away with counselling, but rather to allow healthcare providers to use discernment when 
deciding its extent. This approach was recommended for hospital emergency departments, a 













WHO (2007) revised its RHT guidelines after it was estimated that only 12 percent of men and 
10 percent of women in sub-Saharan Africa were aware of their status. It recommended 
provider-initiated testing and counselling (PITC) at healthcare facilities in sub-Saharan Africa, 
in particular at antenatal, childbirth and post-partum health services. It re-emphasised the 
imperative for “timely detection” of HIV, transmission prevention and access to follow-up 
treatment, care and support. 
 
Botswana - a case study 
 
Only 17,500 of an estimated 110,000 eligible people had enrolled in the Botswana National 
Treatment Programme by January 2004, despite the availability of ARVs from the beginning 
of 2002. This shortfall was largely due to the lack of people being tested for HIV: only 
70,000 of a total population of 1.7 million had tested by mid-2003 (Weiser et al., 2006). Dr 
Banu Khan, National Coordinator, NACA (BONELA, 2003), described the “increased 
desperation by medical practitioners who feel that services offered in Botswana, including the 
ARV programme, are underutilized due to the reluctance of many Batswana to test for HIV”. 
 
In response, stakeholders came together in Botswana in 2003 to discuss RHT from a legal 
perspective. The consensus was that if RHT were introduced properly, it would be a „best 
practice‟ in terms of the epidemic. It was clearly distinguished from compulsory or mandatory 
testing, in which there is no opportunity to decline testing. The objectives were to reach more 
people at an earlier stage of infection (who would be able to access services earlier), normalise 
treatment and remove stigma (BONELA, 2003). Dr Patson Mazonde, Director of Medical 
Services in the Botswana Ministry of Health, stressed “if you do not do [RHT] you are going 
to have a health crisis” (BONELA, 2003). After an announcement of intent by President 
Mogae in October 2003, RHT was introduced in January 2004 in order to increase HIV testing 
and ART uptake (Kenyon, 2005).  
 
Coverage is recommended for the following categories: a) all patients presenting to clinics 
with clinical signs and/or symptoms of HIV; b) pregnant women attending antenatal clinics; c) 
patients with STIs; d) all patients aged 16 and over visiting health facilities who are sexually 
active; and e) any healthy individual going for a general medical exam. Additionally, repeat 
RHT should be offered once a year and/or upon the individual‟s request. Healthcare providers 












but patients are not typically offered in-depth pre-test counselling. Patients may choose a rapid 
or standard ELIZA test and all patients are offered post-test counselling (Weiser et al., 2006). 
 
A general assessment of RHT is provided below, with special attention given to the efficacy of 
Botswana‟s approach and its applicability to SA. 
 
An increase in uptake and awareness of status 
 
Where RHT has been piloted, in a move away from VCT, an increase in uptake has been 
observed. This has been the experience in SA (Bassett et al., 2007), Botswana (Cockcroft et 
al., 2007; Creek et al., 2007), Zimbabwe (Chandisarewa et al., 2007), Uganda (Wanyenze et 
al., 2008) and Kenya (Alcorn & Smart, 2006), and in the USA (CDC, 2001; CDC, 2004a; 
Hamill et al., 2007; Buchbinder, 2006) and UK (Hamill et al., 2007). 
 
Bassett et al. (2007) evaluated the yield of a RHT programme compared with traditional VCT 
at an outpatient department of McCord Hospital in Durban, SA. Only 32 percent tested 
through VCT, of whom 75 percent were HIV-positive (eight cases of HIV infection per week). 
Utilising RHT, 49 percent agreed to a test, of whom 33 percent were HIV-positive (39 cases 
identified per week). The rate of HIV detection using RHT was nearly five-times higher than 
when offering VCT, which convinced Bassett et al. (2007) of the value of introducing RHT in 
a high prevalence setting such as SA. 
 
In Botswana‟s Nyangabgwe Referral Hospital in 2003 (pre opt-out), 50 percent of women 
knew their status at the time of discharge. In the first nine months of 2004 (post opt-out) this 
number rose to 76 percent. Likewise, there was an increase in the number of women who 
knew their status in all 24 PMTCT programme health districts of Botswana, from 52 percent 
in 2003 to 69 percent in 2004 (CDC, 2004b). 
 
A study of routine prenatal HIV testing was conducted at Francistown clinics to assess the 
acceptance and rates of return for care. In a period pre-RHT, 75 percent of pregnant women 
tested in comparison with 91 percent directly after the introduction of RHT. There were also 
substantial increases at the referral hospital in Francistown and at clinics throughout the 
country (CDC, 2004b). Weiser et al. (2006) argue likewise that the introduction of RHT in 












testing. Forty-eight percent of their Botswana sample had tested, as opposed to only 10 to 12 
percent of their Zimbabwe sample, where VCT was practiced (these Zimbabwe figures were 
gathered in 1999). 
 
Alcorn & Smart (2006) describe more than 60,000 tests being carried out in Botswana in 2004 
after the government announced its plan to roll out RHT at health facilities. Uptake of testing 
increased by 134 percent in 2005, and 90 percent of those who were offered the test opted to 
go ahead with it; in the same year, 41 percent were identified as being HIV-positive. 
Additionally, over 90 percent of people who had not tested before tested at mobile clinics in 
Botswana after they were introduced, accounting for 14 percent of people tested in 2005.  
 
After two years of implementation, the estimate by health officials was that 35 percent of the 
population of Botswana knew their status (PlusNews, 2006a). The acceptance of HIV testing 
increased, bringing a concomitant rise in the number of women attending prenatal care and 
persons receiving test results (CDC, 2004b). At the time of a Cockcroft et al. (2007) survey, 
over 50 percent of respondents had been for a test in the past 12 months and of these, the 
majority (49 percent) had been to a routine test provider as opposed to a VCT centre (42 
percent). Of those offered a test, 84 percent went through with it. Additionally, Creek et al. 
(2007) found that RHT resulted in 78 percent of women at a referral hospital in Francistown, 
Botswana, knowing their status at the time of delivery, compared with the previous figure of 
47 percent using the VCT approach.  
 
The results of a study by Chandisarewa et al. (2007), at an antenatal clinic in urban Zimbabwe, 
show that many more women test using the opt-out than the opt-in approach: 100 percent as 
opposed to 65 percent. As a result, more women are identified as HIV-positive: 20 percent as 
compared with 17 percent. 
 
Of people undergoing a routine test for HIV in two hospitals in Uganda who had not tested 
positive before, 25 percent prevalence was detected and 81 percent were being tested for the 
first time. Twenty-eight percent of the first-time testers were HIV-positive and of children 
under 15 years of age, 14 percent were positive, of whom 96 percent had never been tested 
before. Of family members offered an HIV test, 20 percent prevalence was detected 














Almost half of those newly diagnosed with HIV learn of their status within 12 months of 
developing AIDS (Buchbinder, 2006). Early testing avoids such late diagnosis, when a 
person‟s immune system is already compromised. This is one reason the CDC (2006b) prefers 
RHT to testing based on the identification of potential risks, which would have missed a 
testing opportunity 79 percent of the time. 
 
In Botswana, before the introduction of routine HIV testing, most people presented late to 
healthcare providers (BONELA, 2003). Stegling (2004) argues that when resources are 
limited, people presenting early have to wait while treatment is given to such people who are 
ill or have depressed immune systems. Referring to the opt-out testing now practiced in 
Botswana, David Ngele, a Batswana living openly with HIV, states “…people test in time 
[and] therefore receive necessary help before their condition worsens” (PlusNews, 2006a). 
 
Evidence from a teaching hospital in the USA suggests RHT “detected a significant number of 
new HIV infections earlier than might have otherwise been” (Kelen et al., 1999). The 
advantage of early diagnosis of HIV infection for public health (fewer new infections) and 
individual health (earlier access to counselling and health monitoring) is also recognised by 
Bartlett (Bartlett & Mayer, 2006), Hamill et al. (2007) and Wanyenze et al. (2008). 
 
Focusing on SA, Bassett et al. (2007) too describe the importance of early diagnosis and care 
in order to stabilise the HIV epidemic. However – and this is a departure from most research 
findings – they did not find that patients were identified at an earlier stage of infection when 
utilising RHT as opposed to VCT. Also, argues Francois Venter, even routine opt-out 
programmes would fail to identify many HIV-infected people until too late, as they would 
have to visit a hospital in order to be identified (HIV & AIDS Treatment in Practice, 2007). 
 
Improved care provision 
 
Testing for HIV is only one part of the prevention and treatment package. As Macklin (2005) 
states, “critical to the testing process… is systematically linking testing with existing or 
planned treatment or prevention programmes”. And of course, care provision is only possible 












to conduct PITC in healthcare settings, so that the diagnosis and management of conditions 
are possible (HIV & AIDS Treatment in Practice, 2007). Bartlett and Mayer (2006) state that 
more people enter care when HIV is “demystified”, or “normalised” as part of medical care, 
and more HIV-positive people are identified.  
 
A driver of ARV access and vice-versa 
 
Benefits of testing for HIV even when ARVs are unavailable have been discussed above. 
However, the availability of treatment considerably strengthens the argument for opt-out 
testing (Hamill et al., 2007), as policy makers are able to plan an appropriate treatment 
response (Rotheram-Borus et al., 2006). This is why De Cock (2006), director of WHO‟s 
AIDS Department, stresses treatment and care should be scaled up in tandem with PITC. 
 
Chris Green (HIV & AIDS Treatment in Practice, 2007), an AIDS treatment educator, 
describes the non-use of ARVs because people are unaware of their HIV-positive status as “a 
clear violation of human rights”. He stresses that awareness of infection should take 
precedence over a “right to due process in testing”, arguing that a balance is needed between 
human rights protections in settings of limited resources and the protection of millions of 
people. 
 
Stegling (2004), Liddicoat et al. (2006), Weiser et al. (2006), UNAIDS (2006) and Cockcroft 
et al. (2007) argue that more people are testing routinely in Botswana because ARVs are 
readily available and treatment enrolment has increased. Of those surveyed by Weiser et al. 
(2006), 93 percent indicated that RHT would increase access to ARVs. Creek et al. (2007) 
later identified that AZT provision increased from 29 percent in 2003 to 56 percent in 2004 
and upward to 75 percent in 2005 as RHT was introduced at four antenatal clinics in 
Francistown. They also found that women were more likely to know about ARV enrolment 
procedures if they tested routinely. UNAIDS (2006) describes a situation in Botswana at the 
end of 2005 when 85 percent of those in need of ART were receiving it, as opposed to less 
than 20 percent in SA. 
 
PMTCT has expanded rapidly in Botswana since its 2002 introduction and has been provided 
as a routine opt-out test to 91 percent of HIV-positive pregnant women. Ten thousand child 












On a cautionary note, Cheng (2007) draws attention to the ARV waiting list of about five 
million people in sub-Saharan Africa who have been diagnosed HIV-positive. The list of 
people needing treatment and care would only increase with the introduction of RHT, which is 
why the concomitant introduction of ARVs is so important. 
 
A lessening of medical care expenditure 
 
Zackie Achmat, chairperson of SA‟s TAC, argues that early diagnosis and prompt treatment 
avoids people becoming a burden on the healthcare service (Cheng, 2007). Alcorn & Smart 
(2006) describe research in Uganda, which identified that “RHT shifted the profile strongly 
towards asymptomatic patients who needed less intensive clinical management when they 
started treatment”. Before the introduction of RHT, 65 percent of patients had CD4 counts 
below 200 and three-quarters were symptomatic; however, afterwards, only 45 percent of 
patients had a CD4 count below 200 and only 55 percent were symptomatic. 
 
The CDC (2006b) and Delpierre et al. (2007) concur that late diagnosis of HIV considerably 
escalates the costs of hospital care and management of OIs. The additional personal cost in 
terms of lost wages and loss to the economy of the workforce was also noted (CDC, 2006b; 
Chen, 2006). When Chen et al. (2006) analysed the cost of earlier diagnosis in primary 
healthcare in Alabama, USA, they found expenditures for patients with CD4 counts less than 
50 cells/mm3 were 2.6 times greater than those for patients with CD4 counts of 350 cells/mm3, 
as more costly non-antiretroviral medication and hospital care were required. 
 
A reduction in stigma and fear 
 
HIV testing has been treated differently to screening for other diseases and so it has been 
stigmatised (Wynia, 2006), and people who are too fearful of stigma and associations with 
infection, disease and death, have not tested and become ill and die (PlusNews, 2006b). In 
response, choosing to emphasise the routine nature of testing, Holbrooke and Furman (2004) 
propose re-designating VCT by calling it something like „Confidential and Recommended [or 
Routine] Counselling and Testing‟. The CDC (2001) emphasises that RHT would serve as an 
opportunity to combat stigma. Stigma is reduced when testing is offered rather as a “standard 












Referring to Botswana, Stegling (2004) describes the pervasive nature of stigmatising attitudes 
and behaviour or „othering‟, even from healthcare workers. In a survey by Weiser et al. 
(2006), 43 percent of respondents agreed that under routine testing people would avoid going 
to a doctor for fear of being tested. However, 89 percent of the same respondents suggested 
the routine approach decreased barriers to testing and 60 percent indicated that it reduced 
discrimination of PLWHA. 
 
Universal routine HIV screening is considered by the CDC (2006a) to be less stigmatizing 
than testing based specifically on risk, and also manages to identify people who do not 
consider themselves at risk or who fail to report risk behaviour. Hamill et al. (2007) and Creek 
et al. (2007) add that if the general population is tested in healthcare settings, no judgement is 
made about an individual‟s risk, and this would serve to reduce stigma; conversely, 
identification and singling out of particular risk groups (gay men or ethnic minorities or 
women in antenatal settings) sets them apart and reinforces stigma. When RHT was 
introduced in Botswana, Dr Mazonde stressed the importance of avoiding the isolation of an 
individual or group (BONELA, 2003).  
 
De Cock and Johnson (1998) and Gruskin and Jurgens (2005) argue for efforts at 
normalisation to be accompanied by measures, plans and actions to combat stigma and 
discrimination, as policy and legal frameworks have to be in place to protect people before 




As HIV infection carries stigma, there is potential for discrimination and even domestic violence 
in any situation in which there is disclosure, whether undergoing opt-out screening or VCT. The 
International Community of Women Living with HIV/AIDS (2005) raises the issue of violence 
and loss of livelihood that can result after disclosure, particularly when testing with a partner. 
With this in mind, Human Rights Watch (2007) “welcomes the strong emphasis the guidance of 
WHO/UNAIDS places on the need for confidentiality of test results and on countering stigma 
and discrimination”.  
 
If RHT is utilised appropriately, confidentiality should not be an issue. In the case of 












confidentiality was “strictly maintained” (Weiser et al., 2006). Similarly, when government 
health service users were surveyed by Cockcroft et al. (2007) after the introduction of routine 
HIV testing (RHT), 90 percent were satisfied that information about them was kept private 
and confidential. There was no suggestion that there had been breaches of confidentiality 
amongst the remaining respondents. Additionally, six percent of women in a study by Creek et 
al. (2007) at Francistown clinics had reported domestic violence when disclosing their status 
to partners after VCT, compared to none when disclosing in the RHT period.  
 
Coercion, consent and counselling 
 
There is concern among some commentators that the limited amount of information provided 
before a routine test, combined with cultural deference shown towards a doctor and an unequal 
power relationship, does not constitute informed consent (Kenyon, 2005; Gruskin et al., 2008). 
The International Community of Women Living with HIV/AIDS (2005) stresses the 
importance of making information available to women in particular, so that they may make an 
informed choice about whether to be tested. With this in mind, it is encouraging that women 
interviewed after RHT in Francistown, Botswana, reported no instances of being forced into 
testing for HIV; of those who refused to be tested, none reported a difficulty when doing so 
(Creek et al., 2007). The issues of coercion, consent and counselling are important, 
particularly as they have served to polarise the debate around testing for HIV. They merit 




The high cost of VCT was noted earlier, and includes the direct costs of counselling personnel 
and indirect costs for consumers of transportation, childcare, stigmatisation by community and 
psychological effects (Rotheram-Borus et al., 2006). But is there any evidence to suggest that 
the routine approach to testing for HIV is more cost-effective?  
 
There is little research directly out of SA. Bassett et al. (2007) put the VCT cost per person 
tested slightly higher than when utilising RHT. Although the cost per HIV-infected person 
identified using VCT was lower than the RHT approach, Bassett et al. (2007) judged the latter 
approach to be cost-effective. The approach is inexpensive and accurate, and identifies a 












PLWHA, it is also important to consider the cost-effectiveness of ARVs. Research in SA has 
found ARVs to be cost-effective (Badri et al., 2006; Cleary, McIntyre & Boulle, 2006). 
Certainly, the cost of ARVs has markedly declined since 1999 and the Global Fund and 
PEPFAR have committed considerable resources to their use (Chigwedere et al., 2008). 
 
A number of studies conducted beyond SA, and in particular a variety of healthcare settings in 
the USA, suggest RHT is a cost-effective approach. The CDC (2004a), Walensky et al. 
(2005b) and Bartlett (2006) claim RHT for HIV in primary care, outpatient and inpatient 
settings is more cost-effective than colon cancer screening. The CDC described the diagnostic 
expense as being largely due to the need for counsellors, which would decline with the 
adoption of “more streamlined pre-test procedures of providing information about HIV 
testing”. Cost-effectiveness also compared favourably with routine screening programmes for 
diabetes and hypertension (Walensky et al., 2005b) and annual mammograms for breast 
cancer, which are “well accepted tests” (Bartlett, 2006). Frieden et al. (2005) also describe the 
“moderate” cost of routine screening as opposed to other health interventions, claiming more 
effective epidemic control could save between $4 billion and $5.4 billion per year.  
 
A test would be cost-effective, argue Walensky et al (2005b), even when “prevalence of 
undiagnosed HIV infection is ten times lower than recommended thresholds”. They suggest 
the offer of RHT to high-risk groups in emergency departments. Sanders et al. (2005) argue 
for the expansion of routine HIV screening even when prevalence is as low as 0.05 percent, as 
it is as cost-effective as other “commonly accepted interventions” in healthcare settings. 
 
Paltiel et al. (2005) compare HIV counselling, testing and referral (HIVCTR) with current 
practice in high-risk areas, concluding that even in populations with prevalence as low as >1 
percent, “routine, voluntary screening for HIV once every three to five years is justified on both 
clinical and cost-effectiveness grounds”. They stress the need for existing national HIV testing 
guidelines to be promoted, financed and expanded. The CDC (2006b) and Cockcroft et al. 
(2007) also argue universal HIV screening is cost-effective in low prevalence settings, and the 
CDC recommends HIV screening unless the prevalence is less than one in 1,000. Besides the 
financial cost of screening, Pincus et al. (2003) highlight the relevance of therapy 
effectiveness and the probability that further infection will be reduced, when deciding whether 













The need for adequate resource allocation 
 
The challenge of adequately training personnel and ensuring suitable resources are in place 
before the introduction of RHT is recognised by a number of commentators (UNAIDS, 2004; 
Bartlett & Mayer, 2006; Van Rooyen, 2007; Tlou, 2006; Venter, 2007; Human Rights Watch, 
2007; IRIN, 2008; Wanyenze, 2008; Gruskin et al., 2008).  
 
In Botswana, the training of healthcare workers and development of training materials were 
still ongoing a year after the introduction of RHT (Kenyon, 2005; Weiser et al., 2006). 
Implementation difficulties were exacerbated by the burden of long queues and overworked 
staff, for example at Gaborone‟s Princess Marina, the only referral hospital in the south of the 
country (PlusNews, 2006a). Women at clinics have failed to receive HIV test results as they 
are lost or delayed and counsellors are absent (Creek et al., 2007). There is also confusion 
about the process of who should receive a test, what information should be provided and 
what is informed consent, suggests Kenyon (2005), which highlights the need for a 
widespread public education campaign.  
 
In an experience of introducing RHT at a district hospital in Kenya, the workload increased 
considerably, putting staff under stress, and privacy was compromised as space was lacking 
for post-test counselling. An effective response was hindered by the lack of knowledge of 
national guidelines and counsellor skills training (Alcorn & Smart, 2006). IRIN (2008) 
reports that major investments need to be made in the Ugandan public health system before 
RHT can be adopted nationally, including the upgrading of hospital facilities.  
 
Chandisarewa et al. (2007) indicate that in order for widespread implementation of opt-out 
testing to work in Zimbabwe, “high-quality post-test counselling and adequate staffing are 
critical”. They also stress the need for adequate logistical support and laboratory supplies, and 
for the community to be sensitized to the new approach through countryside public awareness 
campaigns. Creek et al. (2007) indicate that public education will ensure knowledge about 
benefits and make people aware they are able to decline both the test and treatment. As nurses 
are already overworked and are therefore reluctant to take on a further onerous responsibility of 
counselling, community counsellors would have to assume this responsibility, as funds are not 













Bartlett & Mayer (2006) highlight the necessity for personnel to be able to provide 
counselling to patients on risk management and care provision, and Van Rooyen (2007) 
emphasises the need to broaden the range of testing personnel, providing remuneration and 
career paths for lay-counsellors. Counselling needs to be culturally sensitive and values-
neutral, so that people are able to disclose their sexual behaviours; this is difficult when few 
doctors speak vernacular languages and patients do not necessarily have a good 
understanding of English. A prerequisite would be for health personnel to be trained “on 
policy, on human rights, and on public education” (Tlou, 2006). Effective health 
communication would also be required to ensure that people know of the implications of a 
routine HIV testing policy (Rennie & Behets, 2006). 
 
Before the routine approach can be effectively scaled up in SA, there is a need for healthcare 
facilities to demonstrate a commitment to roll-out by providing adequate financial resources 
to achieve adequate testing provision with privacy and follow-up care and treatment 
(Wanyenze et al., 2008; Bartlett & Mayer, 2006; Gruskin et al., 2008). HIV & AIDS 
Treatment in Practice (2007) cautions against the introduction of RHT without working 
support systems for those who have learned their results. It calls for appropriate legal 
protections and operational safeguards so that people are not discriminated against. 
 
The importance of leadership 
 
“With strong, supportive leadership, prevention becomes possible; without it, it is extremely 
difficult”, states Whiteside (2008). Human Rights Watch (2007) describes it as a duty of the 
state to provide prevention services, information and ART. The success of Botswana‟s testing 
programme can be attributed in part to its government‟s commitment to fighting the epidemic, 
through resource allocation and a long-established treatment plan (PlusNews, 2006a); Alcorn 
& Smart (2006) and Creek et al. (2007) describe the positive impact of strong political 
leadership at the highest level, together with an effective national media advertising campaign 
and treatment and care provision.  
 
Speaking during the tenure of President Thabo Mbeki, at a time when Manto Tshabalala-
Msimang was Health Minister in SA, Cameron (2006b) indicated that “undivided national 
leadership and unambivalent commitment on AIDS” were lacking and added that “the deepest 












continuing unwillingness or inability to lead effectively and to speak clearly on the issue”. It is 
estimated that more than 330,000 lives were lost during five years of the Mbeki presidency, 
due to the absence of a timely ARV treatment programme (Chigwedere, 2009). 
 
Mbeki‟s successor President Jacob Zuma on World AIDS Day 2009 encouraged persons to 
test for HIV and indicated his willingness to take the test himself (South African Government 
Information, 2009). He has also committed the government to the achievement of universal 
access to ART by 2011, which will require an increase in testing provision. Alarm bells are 
sounded by Butler (2009), who suggests that as the new SA administration attempts to scale 
up ARV access, treatment facilities will be overwhelmed and protest politics will accelerate, 
prompted by the rationing of ARVs. Cleary and McIntyre (2009) describe the need for major 
healthcare spending increases, otherwise resources will have to be diverted from elsewhere. 
They describe the targets of the NSP of 2007 to 2011 as “aspirational”, as the government 
omitted to cost the interventions and targets, which do not take efficiency, equity, affordability 
or accessibility into consideration. At least there have been commitments from the 
international community to support the costs of SA‟s ARV roll-out. The USA alone has 
agreed to fund ARVs to the tune of $120 million over two years, ensuring adequate stocks to 
reach demand (Diplomatic Mission to South Africa, 2009). 
 
Dr John Hargrove, director of the centre for epidemiological modelling and analysis of the 
South African Department of Science and Technology and the National Research Foundation, 
has indicated the cost of providing ARVs to all who need them in SA is affordable, and that it 
is cost-saving to save the lives of people. Prof Hoosen Coovadia (Professor of HIV/AIDS 
Research at the University of KwaZulu-Natal) identifies political will, budget allocation and 
proper use of financial resources as the key issues of successful scale-up (Palitza, 2009). 
 
The workability and acceptability of routine HIV testing 
 
Peer-reviewed literature suggests there is much client support for the routine approach where 
it has been piloted. When opt-out testing is offered, rates of acceptance are much higher, 
indicate Simpson et al. (1998), Weiser et al. (2006), Rotheram-Borus et al. (2006), Wanyenze 













Support has also come from the CDC (which wants a testing acceleration) and those who 
have found fault with the exceptional nature of VCT. Cameron (2006a) is a strong advocate 
of the routine approach, asserting that “diagnosis should be a routine and uncontroversial 
element in the patient management process”. Wynia (2006) favours “medical normalisation”, 
in order to make HIV diagnosis “at least as routine as getting colonoscopies, Pap smears, and 
cholesterol checks”. Gruskin and Jurgens (2005) suggest a provider-initiated model is best for 
a number of reasons. Some key reasons, explained by Weiser et al. (2006), are to “increase 
the proportion of individuals aware of their status, and thereby reduce HIV exceptionalism, 
lessen HIV-related stigma and provide more people with access to life-saving therapy”. 
 
Weiser et al. (2006) found that Botswana‟s routine approach was acceptable to clients and had 
reduced barriers to testing. Eighty-one percent of respondents were strongly in favour of such 
testing and eight percent indicated they were somewhat in favour. A higher 93 percent 
indicated that it would increase access to ARVs, 89 percent agreed the approach made it easier 
for people to get tested and 92 percent reported that they were encouraged to send others for 
testing after a favourable experience.  
 
Cockcroft et al. (2007) randomly sampled households across Botswana to elicit views about 
RHT and ART. Of those surveyed, 94 percent indicated they were in favour or strongly in 
favour of RHT, as: a) it encourages people to get tested (68 percent); b) people can quickly 
access treatment (17 percent); and c) the spread of HIV is slowed (16 percent). Over 80 
percent of respondents had used a government health facility in the last 24 months, since the 
introduction of RHT, and of these 92 percent were satisfied or very satisfied with the visit and 
96 percent reported being treated with respect. In another study in which antenatal care clients 
were interviewed, Creek et al. (2007) failed to identify from them any adverse consequences 
from the introduction of RHT in Botswana. 
 
Client satisfaction was also evident in a survey of women receiving routine opt-out testing at 
an urban antenatal clinic in Zimbabwe (Chandisarewa et al., 2007). Ninety-nine percent 
understood why blood was being taken, 98 percent felt prepared for the receipt of positive 
results and 99 percent were satisfied with information provided in order to effectively manage 
their health. The number of women attending the antenatal clinics or receiving their test results 
did not decline. On the contrary, 89 percent of women reported they were empowered 












decisions about PMTCT and infant feeding”. A higher number of women and infants received 
prophylaxis than in a period of opt-in testing, and more women enrolled in a mentorship 
programme, joined a support group, and attended the clinic with their babies for follow-up. 
 
Nakanjako et al. (2007) are also quick to recommend RHT and counselling (RTC) as the 
standard of care in a Ugandan hospital emergency unit, describing it as a device to scale-up 
diagnosis and “an entry point to comprehensive prevention and care”: 95 percent of patients 
offered RHT accepted and 99 percent indicated it should be permanently integrated, with 86 
percent asserting that it would help linkages to care for ART and treatment of OIs. 
 
In a later study, Wanyenze et al. (2008) reaffirmed the acceptability of HIV testing and 
counselling when they collected data at two large tertiary hospitals in Uganda. RHT and 
counselling for HIV had been introduced in November 2004. Of those persons offered a test, 
98 percent accepted. Of those refusing, 21 percent agreed to be tested after their illness 
improved and 20 percent indicated they were already aware of their HIV-positive status. 
When family members were also offered an HIV test, 93 percent accepted, of whom 73 
percent had never before tested. The authors do caution, however, that the high rate of 
acceptance could be due partly to testing being made available gratis, which is already the 
case in SA.  
 
There is support in particular for the introduction of RHT for pregnant women. Research in 
SA by Bassett et al. (2007) shows that significantly improved case findings come from the 
routine offer of a test, rather than “testing based exclusively on physician assessment or 
pregnancy status”. With PMTCT, uptake is 91 percent and transmission is down from about 




Advocates of RHT concur that with ART increasingly available, there is every reason to 
accelerate the utilisation of this approach (Jaffe, 2009). The CDC, UNAIDS and WHO have 
committed to its promotion, particularly in high prevalence settings, of which SA is one. 














For such an approach to work, confidentiality must be ensured and the test must be offered 
without coercion, in spite of relationships of inequality between healthcare providers and 
clients. Of considerable importance is adequate resource allocation and training of personnel 
before such a system is introduced. Additionally, there is a role for leadership within 
government to ensure acceptability by clients. 
 
In Botswana public acceptance of RHT and government support have been high. The numbers 
testing and becoming aware of their status has grown and earlier diagnosis has allowed for 
more cost-effective medical management and better health. Provision of ARVs has 
importantly come hand in hand with the expansion of this approach.  
 
The question remains, however, of whether this approach to testing is replicable in SA. After 
describing my research methodology, I will proceed to detail the responses of my informants 
















This thesis has been based predominantly on a review of significant literature pertaining 
mainly to testing for HIV, and interviews with key informants at the forefront of prevention 
and treatment of HIV and AIDS in SA. 
 
I embarked on a literature review for a variety of reasons. I wanted to focus on the most 
credible and updated sources of information, particularly with regard to RHT, the practice of 
which has grown substantially over the past few years. My intention was to build on existing 
knowledge and ideas and at the same time identify where there may be gaps in the literature. 
It was important for me, when positioning my work, to have an intellectual context for the 
content, and to be able to provide divergent viewpoints. 
 
Much of the reviewed literature is particular to the USA and Western Europe, where 
prevalence is far lower and healthcare capacity is much greater than in SA, the primary focus 
of this research. Additionally, there are differences in the population groups affected and the 
clade of the virus. Despite these acknowledged shortcomings, the literature is utilized due to 
the scarcity of data from the numerous HIV-related interventions in SA (and sub-Saharan 
Africa as a whole, for example regarding cost-effectiveness). The experience of RHT has 
been under-researched in SA and there is a paucity of evaluations pertaining to the country‟s 
experience of the practice. There too are few complete reviews of VCT. Importantly, when 
examples are drawn from literature external to SA, and even to sub-Saharan Africa, there is 
clearly relevance and applicability to the local context.  
 
I have only drawn on external literature when it is clearly relevant and locally applicable. 
Where possible, Western examples are balanced with the experience of sub-Saharan Africa, 
more specifically Botswana, Zimbabwe and Uganda. It is important to recognise that these 
countries, even those bordering on SA, have differing contexts, with regard to population 
density, resources, cultural factors and more. Even within SA, there are inequalities across 
the health system and disparities exist between public and private provision and between 
rural and urban populations. Resources are located predominantly within urban centres and 













Following a thorough literature review, I required a more direct, individual and localised 
experience of testing for HIV. I therefore chose the qualitative approach of semi-structured 
interviews with South Africans who are experts in their respective fields. I sought first an 
understanding and then a deeper insight from local practitioners, in order to learn what they 
thought about the topics. Their descriptions in interview were in vivid detail, with a richness 
and complexity of personal experience that translated into valuable case study examples. 
 
The approach of open-ended interviews allowed me to appropriately tailor further questions. I 
was able to probe the culturally relevant responses, as well as personal histories and 
perspectives. These were quite unique, particularly as the strong personalities of the 
individual respondents came to the fore. For some, an impassioned response was born out of 
frustration at what they perceived to be a lack of progress or limitations in the present 
approach. All respondents agreed to be publicly identified, with none appearing to be 
concerned with the need to maintain anonymity.  
 
After each interview I was able to return to the existing literature, much of which although 
relevant to SA is the experience from elsewhere, with a fresh perspective. Information 
gleaned from my respondents assisted me to uncover relevant and interesting theories and 
hypothesis, and gain something of an insight into the diverse range of responses to this rather 
difficult and controversial topic. 
 
It was important for me to select a broad base of key informants for interview, when eliciting 
opinions and beliefs. They included public health professionals (clinicians, epidemiologists), 
academics (physician, health economist), service providers (nurses, occupational health 
professionals), and a prominent PLWHA. All were able to provide in-depth qualitative 
information on the VCT response to HIV prevention, as well as alternative approaches, 
including RHT for HIV. This is because their expertise is informed by their roles of clinician, 
healthcare professional and affected person. As they are on the frontline of responding to the 
HIV epidemic in SA, they were all able to draw on practical experience and invariably the 
most current processes, best practices or techniques under trial when discussing the challenge 













All informants responded in an unstructured style and recordings were transcribed. Although 
they have differing areas of expertise, issues raised were similar and there was often a 




Dr Linda-Gail Bekker is a physician, currently located in the Institute of Infectious Diseases 
and Molecular Medicine (IIDMM) on UCT‟s Medical School campus. She chaired the SA 
AIDS Conference in 2009. She is a principal investigator at the Desmond Tutu HIV 
Foundation (DTHF), established in January 2004 under her directorship and that of Professor 
Robin Wood. The Foundation is well known as one of the first public clinics to offer 
antiretroviral therapy to PLWHA. More recently, the Foundation extended its activities to 
include HIV treatment, prevention, training and tuberculosis treatment monitoring in the 
hardest hit communities of the Western Cape. 
 
The DTHF is one of the leading research organisations in SA, which seeks innovative ways 
to provide HIV testing, explores the interaction between HIV and TB and tries to find ways 
to prevent HIV, particularly in vulnerable groups. A goal of the DTHF is to impact policy 
and outcome, through evidence based methods, peer review publications and dialogue with 
community and service providers. Bekker is outspoken in advocating for a public health 
intervention on a scale that the SA HIV epidemic demands. Her key research interest is the 
host response to tuberculosis infection and an important recent initiative of the DTHF is the 
trial of a mobile HIV testing station, called the Tutu Tester. 
 
Constitutional Court Justice Edwin Cameron, previously a Supreme Court of Appeal Judge, 
is the first senior SA official to have stated publicly that he is living with HIV/AIDS. He was 
inspired to publically disclose after the stoning and stabbing to death of Gugu Dlamini when 
she declared her HIV-positive status. Cameron is also a prominent gay-rights activist. 
 
At Oxford University, Cameron researched 'Aspects of the AIDS Epidemic, examining in 
particular the denialist stance supported by SA President Mbeki'. Whilst employed as a 
human rights lawyer at the University of the Witwatersrand's Centre for Applied Legal 
Studies (CALS), he co-drafted the Charter of Rights on AIDS and HIV, co-founded the AIDS 












the Patron of the Guild Cottage Children's Home, of the Soweto HIV/AIDS Counsellors' 
Association (SOHACA) and of Community AIDS Response (CARE). He is the author of the 
award-winning book, „Witness to AIDS‟. 
 
His dedication to advocating for human rights and championing the cause of HIV and AIDS 
has won him many awards and distinctions, including the Nelson Mandela Award for Health 
and Human Rights, Transnet's HIV/AIDS Champions Award and the San Francisco AIDS 
Foundation Excellence in Leadership Award. His reflections on the impact of stigma and his 
impassioned call for the de-medicalisation of HIV were discussed in interview.  
Dr Susan Cleary is the Director of the Health Economics Unit at UCT, where she has been 
since 2001. She holds a Bachelor of Arts degree in Economics and English, a Masters in 
Economics and a PhD in Health Economics entitled „Equity and efficiency in health and 
healthcare for HIV-positive adults in SA‟. 
Cleary convenes the Postgraduate Diploma in Health Economics and coordinates and teaches 
on a number of modules on the Masters in Public Health, specialising in Health Economics. 
She is also the coordinator of the Health Economics and Policy Network in Africa - a 
network that aims to develop health economics capacity through working with academic 
institutions and policymakers in eight African countries. Her research focuses in particular on 
the economics of HIV treatment and prevention, primarily in the areas of equity, efficiency 
and the costs of scaling-up.  I interviewed her on the cost-effectiveness of testing and ARV 
provision in SA and resource allocation in the health system in general.  
Dr David Coetzee, the founding director of the Infectious Disease Epidemiology Unit in 
UCT‟s School of Public Health and Family Medicine, is a public health specialist and 
epidemiologist with many years operational experience in primary care and infectious disease 
service delivery. He has led a number of clinical epidemiology research projects in the areas 
of tuberculosis, HIV/AIDS, immunisation and STIs. He was able to draw on his considerable 
experience as a clinician at the Médecins Sans Frontières (MSF) clinic in Khayelitsha in the 
Cape Town metropole. 
Dr Rodney Ehrlich is a professor at the School of Public Health and Family Medicine at 
UCT. He is a senior specialist at the Occupational Diseases Clinic, Groote Schuur Hospital, 












research interests include the epidemiology of chronic lung disease, including tuberculosis; 
social epidemiology; and occupational and environmental health, including diagnosis, 
treatment and compensation of occupational disease. 
 
Ehrlich consults to the Division of District Health Services and Programmes, Department of 
Health, Provincial Government of the Western Cape and is a member of the Executive 
Council, College of Public Health Medicine of SA. His special education interests include 
occupational medicine and public health; research methods, social epidemiology and 
epidemiology of non-communicable disease.  
Dr Ashraf Grimwood is an HIV clinician and chairman of the National Aids Convention of 
SA. He was Cape Town's Principal Medical Officer and then a director of Secure the Future, 
a philanthropic project of Bristol-Myers Squibb dedicated to responding to the AIDS 
epidemic in southern Africa. He has commissioned HIV research that impacts on public 
health policy. 
Together with Zackie Achmat, known for his advocacy role with the TAC, Grimwood helped 
start community healthcare in the poor area of Bellville South. He was formally educated in 
public health in Australia, setting up the Tasmanian Aids Clinic in 1989 and later heading the 
Tasmanian Aids Council.  
Grimwood is the executive director for ARK in SA, which treats HIV-positive caregivers and 
is expanding its antiretroviral (ARV) treatment programme for children. ARK works in 
public health institutions, introducing to the system doctors and nurses with HIV/AIDS 
expertise as well as pharmacists. 
Dr Gary Maartens is associate professor in the Division of Clinical Pharmacology within 
the Department of Medicine at UCT, who founded and now heads the HIV Clinic at Groote 
Schuur Hospital. He trained in Cape Town and completed an infectious diseases fellowship 
in Birmingham, UK. He has served in hospitals in the UK and SA and has held the positions 
of medical officer and registrar. He has published widely in the field of infectious diseases 
and serves on local and national health policy committees. He was asked to draw on (in 












Margie Tainton holds the position of Organisational Health & Retirement Manager in the 
Human Resource Management Department of UCT. Her colleague, Ashley Taylor, is 
Organisational Health and Wellness Advisor in the same department. They have been 












CHAPTER FIVE: DISCUSSION – ADAPTING TESTING FOR HIV IN SA 
 
Pre-test counselling and human rights 
 
All informants agree there is considerable value in testing for HIV. However, they are not 
overly impressed with the VCT response. Those who have regularly met over a number of 
years with clients to conduct HIV testing generally see little value in pre-test counselling. 
 
Some informants suggested pre-test counselling should be kept to a minimum, as resources are 
few and time is scarce in the health system. There would only be benefit in briefly discussing 
worries and giving reasons for undertaking the test (Ehrlich, 2007; Maartens, 2007). Ehrlich 
(2007) states time and resources are not available to engage patients in a hypothetical space 
before a test, or to tell people to rather go away and think about why they should get tested.  
 
Others argue for the complete elimination of pre-test counselling. Cameron (2007) speaks of 
“the almost comprehensive failure” of VCT and describes a misconception that it is voluntary; 
this suggests people with HIV or at risk of transmission are going to make an excessive effort 
to present themselves for testing. He calls this abnormal and indicates that people do not 
volunteer for something normal:  
 
“you cannot talk about normalising HIV in an abnormal situation, I realise that... so 
one‟s trying to lance a paradox, to breach a paradox… that HIV is still highly 
abnormal”.  
 
As ARVs are more freely available, there are increasingly calls for HIV to be normalised and 
regarded as a chronic (treatable) medical condition. Cameron (2007), arguing that his human 
rights colleagues are battling to shift from an outmoded paradigm, argues that the exceptional 
response of pre-test counselling is inappropriate, as the condition it screens for is comparable 
to insulin dependent diabetes, a heart rate issue or chronic hypertension. He states that, as SA 
has the biggest public sector-provided treatment programme in the world, the need is to 
encourage and not discourage persons from getting tested. To him, VCT is an incorrect 
approach, in theory and principle, justified only when no treatment is available. He indicates 
that people prefer not to be tested when the exceptional and unusual nature is emphasized, 












Grimwood (2007) and Bekker (2008) similarly state that pre-test counselling should be merely 
consent, rather than working on various scenarios, as the client may be HIV-positive or 
negative. As much of the counselling is about information, states Grimwood (2007), people 
who have tested before do not need to go through pre-counselling again. Bekker‟s 
understanding, much like that of Maartens (2007), is that time can best be spent after a test 
describing what can be done for the person who is either HIV-negative or positive. 
 
Bekker (2008) questions whether pre-test counselling is actually working against us, in that 
we continue to create an illusion of secrecy and contribute to the stigma and the discrimination 
in the name of confidentiality. She goes so far as to suggest that in the name of safeguarding 
peoples‟ privacy rights, we have actually completely undermined their rights to health and 
good care. 
 
Maartens (2007) suggests that the approach to testing for HIV is something that SA has not 
fully grappled with, despite its identification as a key issue. Tension remains between human 
rights advocates and public health practitioners. He indicates Botswana has led the way, and 
that the South African Department of Health needs to take up testing more seriously and more 
properly. 
 
All informants responded passionately to the contentious issues of coercion, counselling and 
confidentiality. Maartens (2007) accepts that human rights advocates are wary about opt-out 
testing, as they do not want the rights of people to be eroded, but stresses the need to be 
pragmatic. He acknowledges it would be coercion if a doctor argued that s/he would not treat 
someone unless they agreed to a test, but emphasises that patients generally come to hospital 
to be helped, and when they realise their condition is serious they are open to testing. He 
admits to pushing people hard on occasion to get tested, but asserts he has never coerced or 
refused to treat anybody.  
 
Maartens (2007) states if a person is unable to provide consent, a doctor orders an HIV test, in 
the same way s/he would remove a clot on the brain without insisting on consent. He would 
essentially do what is in the interest of the patient, going about the testing process thus: if a 
patient has lost a lot of weight, he would consider the cause to be thyroid disease, cancer, 
AIDS, TB, anorexia, or perhaps a mal-absorption complaint. If there were no obvious 












patient that the blood he is pulling is for their thyroid. However, if it were positive, he would 
indicate they have an overactive thyroid gland and he would have to do a particular procedure. 
He questions why he should not do the same for someone with HIV.  
 
Bekker (2008) describes 70 percent of the patients in the medical wards at Groote Schuur 
being HIV co-effected. She indicates that if it was known that the same percentage had 
prostatic carcinoma, a prostate specific antigen (PSA) would be performed, yet the response of 
screening is not automatic. Rather, “we stand around, we dance around, some of them (the 
patients) are semi-comatose and we institute ridiculous care”. She has not experienced a 
person refusing to be tested for HIV and feels if it is marketed appropriately it is acceptable to 
people, in the same way that it would be acceptable to remove an appendix that is about to 
burst. She believes in taking responsibility to use the information that a doctor has to hand, 
whilst at the same time respecting peoples‟ privacy and right to confidentiality. 
 
There are opportunities for exploitation, accepts Bekker (2008), for example when commercial 
sex workers are abused in Indonesia because they need to be tested. However, she explains 
that this is not about the test but rather a country with flawed human rights. She sees the issue 
around consent as a “gatekeeper” to giving people better care: “People can volunteer and go 
get tested, but for some reason they‟re not, and that‟s because we‟re continuing to collude that 
there‟s something unusual about this test verses getting a blood pressure test or getting your 
prostate checked… it shouldn‟t be… it‟s a medical condition that has a treatment”. She 
stresses the need to pursue the normalisation of HIV. 
 
Ehrlich (2007) emphasises the need to obtain consent, making sure there is sufficient time for 
essential post-test counselling and to focus attention on preparing someone who is HIV-
positive. For someone who is HIV-negative, the healthcare provider simply needs to indicate 
that this is an opportunity to stay negative and give two or three key messages. He states that 
opt-out testing works when a doctor uses the levers of authority to get people through the 
system: “It just doesn‟t work with a highly elaborate consensual model”. He questions 
whether on balance this is a good idea, adding that if we are to make testing work, it is 
important to weigh up interventions and the prospect of big gains against insubstantial costs. 
 
Cameron (2007) objects to the word „coercive‟, finding „directive‟ more appropriate: “When 












directive”. He emphasises that talk of coercion melodramatises the situation; coercion is a 
doctor saying s/he is not going to treat you unless you do an HIV test, and if it is positive s/he 
is not going to treat you at all. Importantly for Cameron, the change to testing that he 
advocates assumes protection from discrimination, beneficent healthcare providers and the 
availability of treatment. 
 
Stigma and confidentiality 
 
Cameron (2007) describes AIDS as “probably the most stigmatised disease in human 
history”. This is despite the fact that there is no possibility of contagion – unlike tuberculosis, 
bubonic plague and leprosy – and “even though transmission can occur only under well-
defined, exceptional circumstances”. He adds that efforts at prevention have been disabled by 
“the inner feelings of contamination, shame and self-disentitlement”. 
 
It is difficult for Cameron to comprehend why, despite knowledge of treatment for more than 
12 years, affordable treatment for upwards of five years, and a public commitment to 
treatment in November 2003 by the SA government, and in Botswana from 2001, stigma is 
still so prevalent. He surmises it is due to the link between sexual transmission and internal 
stigma, which “is totally under-examined, totally under-researched, totally under-understood”. 
He suggests that VCT, because of the burden it places on the care-seeker, does not deal with 
this question.  
 
Grimwood (2007) stresses that a testing service has to be anonymous enough for someone to 
be tested without confidential information being made public. He illustrates this point by 
describing a little clinic in a small village in which all inhabitants know one another. At least 
with RHT, when the testing facility is not set apart from the rest of the healthcare facility, 
there is less likelihood of the community knowing why a person is going to see a healthcare 
provider. However, whichever system of testing is utilised, a stressed healthcare system does 




All respondents indicate the role of leadership is important in securing the acceptance by the 












under the Mbeki Presidency, but decried the absence of leadership from the then South 
African Department of Health under Tshabalala-Msimang. She wanted to see the President 
standing up and having an HIV test, which Jacob Zuma has now done (South African 
Government Information, 2009), in addition to his family, the Health Minister and others. 
Grimwood (2007) is also critical of the “fantasy, fear and obfuscation”, when the need is 
rather to normalise HIV; to talk openly and bluntly about the risk activities and about getting 
oneself tested, knowing one‟s CD4 cell count and getting oneself onto treatment. Additionally, 
he emphasises the need for regular and consistent campaigns in the media, by Komenani and 
others, rather than irregular and sporadic efforts. 
 
Coetzee (2007) argues that people failed to test under the government of Mbeki because 
testing had not been taken on at a political level, due to associations with stigma. He argues 
that VCT has not failed in itself, but rather that its lack of success has been due to the historic 
insufficiency of leadership and the denying and ignoring of HIV. Ehrlich (2007) adds that the 
disease has consistently been re-stigmatised, with a historic absence of leadership and 
openness. He argues that to diminish the stigma we need not only individual and contextual 
change, but also strong political leadership. 
 
Bekker (2008) argues that if people consider something to be „kosher‟, they adopt it. 
Therefore, she feels if more role models (celebrities, sports personalities, influence-leaders, 
including politicians, academics, business persons and religious leaders) step up and say this is 
the way to go, with an explicit endorsement, more people may test. The benefits and value 
need to be clearly stated. Maartens (2007) also highlights the need for bold leadership at 
national level, particularly as there are huge disparities in terms of treatment provision 
between all provinces in SA.  
 
Expanded testing effort 
 
The consensus from a literature review is that a “greatly expanded testing effort” is needed to 
impact the transmission of HIV (Marks et al. 2006), but questions remain as to the most 
appropriate response. There too was a consensus among informants about the value of 
adopting a number of approaches, but also a general feeling that VCT should not be discarded 
altogether. Maartens (2007) cautions against throwing out VCT, suggesting it could be done 












“We need to really interrogate what we mean by how much time and how expensive is it and 





Informants chose to grapple with a handful of alternatives to VCT. I alluded in interview to 
Francois Venter‟s controversial call for mandatory testing of all South Africans in a Sunday 
Times editorial in 2007, born of the frustration and despair he was experiencing as colleagues 
were needlessly dying of AIDS. He describes a “collective denial about HIV” that was 
stopping people from getting tested. 
 
Venter proposed a universal testing policy, utilising incentive-linked systems, or testing by 
compulsion and having to present proof of a test when applying for papers and services, such 
as drivers‟ licences, bank cards, marriage licences and pensions (HIV & AIDS Treatment in 
Practice, 2007). He argued that this would place the onus on the individual and that legislating 
for such testing has precedents, including the wearing of seatbelts. 
 
In literature, Mark Heywood of the TAC is forthright in his response to Venter‟s call: “The 
suggestion that we should introduce some sort of coercive thing, that‟s pushing it ridiculously” 
(HIV & AIDS Treatment in Practice, 2007). Van Rooyen (2007) asserts that the mandatory 
approach only serves to increase stigma and does little to encourage behaviour change. 
 
Bekker (2008) supports people being tested at significant life moments, such as when entering 
school and employment - if acceptable and accessible - but acknowledges that SA is not yet 
ready. She suggests Venter is playing devil‟s advocate to get the debate going when he calls 
for mandatory testing. His primary aim is to get people thinking innovatively, with the end 
goal of getting people into care and more effective service provision. Mandatory testing has 
not been extensively debated in SA, which is perhaps partly due to a strong emphasis in the 














Routine HIV testing 
 
Regarding the opt-out approach, Grimwood (2007) and Coetzee (2007) suggest the “spirit” of 
RHT has in fact been in operation in SA for a number of years, in STI clinics, TB clinics and 
with PMTCT. If a nurse or doctor has diagnosed TB, which would indicate a likelihood of 
HIV, the need for testing is proposed. However, Grimwood (2007) indicates that protocols 
are followed to the „T‟, which becomes problematic as testing is prevented from happening. 
He would prioritise normalising HIV testing for all pregnant women, as they have been 
participating in a high-risk activity (sex without a condom) and so they may have been 
exposed to the HI virus. There is also risk of an STI, such as human papaloma-virus or herpes 
simplex. He sees this as a valuable use of resources, particularly with SA‟s high prevalence 
rate, but would not even discount the possibility in lower prevalence settings such as Britain. 
 
Cleary (2008) suggested the targeting of RHT at “hot-spots” would be most beneficial – and 
states that everyone knows where the worst prevalence is. She describes equitable service 
provision as a situation in which one targets where there is most need and where the biggest 
numbers can be reached, rather than spreading limited resources so thinly that there is no 
benefit. She acknowledges this controversial approach would challenge the right (enshrined in 
the constitution) of all South Africans to healthcare provision. 
 
Maartens (2007) and Ehrlich (2007) are very sympathetic to the opt-out strategy for certain 
categories of individuals, where there is an immediate benefit to their health. They recognise 
the value of targeted testing, emphasising that everyone with TB and those coming for 
reproductive health services should undergo an HIV test. Ehrlich states this is not happening 
enough, although he does suggest the profiling of people could become problematic, as 
selective, opt-out targeting could become racially based. Targeted testing could be effective if 
linked to likely medical presentations, such as OIs. He indicated that when he was an intern, a 
syphilis test was done as a matter of course when a person was admitted to hospital – there 
was no profiling; it was done as a public health measure, with the opportunity of diagnosis and 
treatment. Similarly, HIV is easily diagnosed and treatable. Maartens (2007) indicates the 
Western Cape already does targeted testing for persons visiting TB clinics and describes this 














Grimwood (2007) and Maartens (2007) would also test persons presenting with STIs, as they 
would have had unprotected sex and be at risk of HIV infection. Adopting a public health 
stance, Maartens (2007) speaks of insufficient efforts to date to offer testing to every person 
who is entered into primary care for an STI. He recognises that testing becomes more difficult 
at the hospital level, when there are so many infections presenting in a number of ways. 
 
Maartens (2007) states RHT for HIV has an immediate benefit for the infant and the mother, 
in terms of treatment interventions. For pregnant women, it is not to their benefit so much as 
to the baby‟s, but most women would likely see that as an immediate health benefit. 
Therefore, when the standard VCT approach does not reach this population group, as is the 
case in a number of provinces in SA, the opportunity is there to take blood and test for HIV, 
with an opt-out option. When targeted at the specific patient population, there are both public 
health benefits and more direct benefits to those specific groups. 
 
This diagnostic approach is endorsed in literature by De Cock (2005), for example at health 
facilities in high prevalence settings or with TB patients. Hausler et al (2006) indicate that if 
prevention and care interventions for TB and HIV are linked, the estimated costs of preventing 
TB are less than previous estimates of costs of treatment. Where targeted or risk-based testing 
becomes problematic is when there is no perception of risk. When this perception is absent, 
people fail to go to be tested (Bartlett, 2008). This is why persons suggest a combination of 
approaches – targeted testing and broad-based screening campaigns (Marks et al., 2006). 
 
Coetzee (2007) indicates that “champions” at some clinics are adopting the routine approach 
and both the voluntary and provider-initiated approaches are necessary. Maartens (2007) 
would preserve the walk-in clinic, complete with counselling, where a healthy person walks in 
out of curiosity and wants to be tested. He also believes in supporting any strategy that would 
improve the rate of testing and not have any negative outcomes.  
 
Ehrlich (2007) suggests a number of systematic approaches to testing. Opt-out opportunistic 
testing – as a public health measure, without targeting – would be suitable when there is no 
obvious indication: for example, drawing blood when one goes for a tonsillectomy. 
Additionally, doctors could try to identify at-risk patients, for example those with pneumonia 













Although Maartens (2007) has reservations about RHT, he is sympathetic to such an approach 
for sick patients or antenatal women, provided it is done with good post-test counselling and 




I asked informants whether other approaches are workable. Grimwood (2007) feels home 
testing might work in SA if it were done by properly trained personnel, with test kits approved 
by the Medicines Control Council. He emphasises this, as the use of faulty test kits has 
resulted in false positives, and indicates that if community care workers were properly trained, 
home testing might be an option, more particularly in deep rural areas. This is an approach 
that has been under-researched, but a detailed analysis is beyond the scope of this thesis. 
 
Wellness screening and mobile testing 
 
Ehrlich (2007) and Bekker (2008) explain as critical the need to reach the population of men 
that generally do not go to see healthcare providers. They emphasise that there is a need to 
achieve community acceptance, and to rid stigmatising attitudes, and this could be achieved by 
the integration of testing into other care. Bekker (2008) suggests the test should be brought to 
them at workplaces, or wherever they are, which would make testing accessible. She reasons 
that in a country in which one in three adults in some communities are infected with HIV, 
there is every reason to bring testing to where there are large numbers of 20 to 50 year old 
adults, or the high-risk 15 to 20 year old adult grouping.  
 
Bekker (2008) stresses the need to instil in the SA populace, which does not consider 
prevention strategies sufficiently, the need to test for HIV as a formality. She would attach it 
to lifestyle or „wellness‟ – living long and healthily – so it becomes just like having one‟s 
blood pressure or sugar level tested. She would emphasise testing to stay healthy, rather than 
to protect one‟s partner, and stress the benefits of getting into care earlier and living longer, 
and if HIV-negative, staying negative. She stresses that an offer of testing needs to be simple 
and easy, with little time involved – so the workplace is a good location at which to test, as it 
is accessible. She also states that a new way of thinking is required, in which the individual 
takes responsibility for their own wellbeing to a greater degree than has traditionally been the 














Wellness initiatives involve health screening for common lifestyle diseases, including HIV, 
Hypertension, Hyperlipidaemia (Cholesterol), Diabetes and Body Mass Index or BMI 
(Obesity), with a finger prick for blood and a maximum of only 20 minutes duration. Not 
unlike a routine approach, there is seldom emphasis on pre-test counselling. The effectiveness 
of this approach and reasons for its success are explained below using the case study example 
of UCT. 
 
VCT was offered to staff at UCT until early 2007 and uptake was low, despite attendance 
being encouraged by blanket communication and industrial theatre. Margie Tainton (2007), 
UCT‟s Organisational Health and Retirement Manager, describes “a handful trickling in”: 10 
to 20 per session. The most successful VCT uptake was at UCT‟s Graduate School of 
Business, where leadership actively encouraged participation. When a small sample was asked 
why staff were not testing at UCT, most respondents replied they were sure of their negative 
status and did not consider themselves to be at risk. Only 353 people (or fewer, as many were 
retests) of an eligible 3,000 and a target of 850 had been for VCT from 2003 to 2005, at a 
considerable financial cost to the institution. The low uptake encouraged the establishment in 
2007 of a pilot wellness initiative. Tainton (2007) explains that in providing five tests and an 
option to opt-out, “there is no measure of forcing” and “we are hoping they will think, well, I 
may as well have all of them… with only one prick of blood”.  
 
This effective utilisation of resources does not emphasise testing for HIV per se, but rather 
wellness and lifestyle testing, in an effort to destigmatise HIV and make it similar to other 
manageable chronic diseases. The provision does enable early detection and management of 
HIV, although the client may opt out of any test. It is about the client taking responsibility for 
their health. In one department - the Office of the Vice-Chancellor - over only 2 days in 2007, 
119 people came forward for wellness testing, with only four opting out of the HIV test. The 
experience of subsequent interventions, until September 2008, was of 86, 92, 94 and 100 
percent uptake: the lowest opt-in of 86 percent may be explained by the fact this was a one-
year follow-up in a department already tested. 
 
Ashley Taylor (2007), Organisational Health & Wellness Advisor at UCT, explains that 












refreshing it with them. The main concern is post-test counselling and getting a person safely 
to the counsellor and into care. The wellness initiative will move through Faculties at UCT, so 
that all staff are given an opportunity to test. They are likely to opt-in, as the tests are brought 
to them, confidentiality is assured and the service is not stigmatised (the test is a healthy thing 
to do – part of a holistic “wellness package”).  
 
Attendance is incentivised with the gift of an “I know” bracelet and the offer of Vitality points 
that translate into medical scheme benefits. As permanent staff at UCT are obliged to join a 
medical aid scheme, treatment is available as a prescribed minimum benefit at no extra cost 
and significant savings have been made by changing the service delivery model. 
 
Bekker (2008) stresses the importance of approaching therapy in a more managed way, rather 
than through crisis management, when a person learns their HIV-positive status when they 
already have TB or Cryptococcal Meningitis, for example, and a CD4 count at virtually zero. 
She indicates that people need to be identified at the time at which they are HIV-infected, but 
not diseased, or infected but not symptomatic, and entered into care, with a thorough 
monitoring of their CD4 cell count. She asserts that VCT fails to achieve this, as it relies on 
people coming forward because they are sick and their immune systems are already 
compromised. It is harder to put such people on treatment, and often more expensive, as 
medical care (and hospitalisation) is required.  
 
In response, her DTHF has from May 2008 offered testing for HIV to various communities in 
the form of a Tutu Tester mobile clinic, along with screening for other chronic conditions of 
hypertension and diabetes, as a way to normalise the test: “The concept represents the 
DTHF‟s vision that HIV should become viewed as a chronic treatable condition rather than 
one attached to stigma, discrimination and shame”. 
 
Follow-up provision is immediate. Those testing positive receive a CD4 count test (which 
only takes ten minutes), in order to assess whether ARVs are required, TB screening, some 
STI screening and a pregnancy test – intelligent referral and comprehensive treatment. In this 
way, testing is taken outside clinical settings and the mobility takes it to clients who might 














The nature of testing as a self-initiated activity serves to further normalise the testing process, 
and it is highly accessible, flexible, fast and efficient, serving to encourage people to test 
regularly (the mobile facility returns to the same location every three months). Risk reduction 
counsellors offer goal-oriented risk reduction and positive living action plans. Particular 
groups are targeted, such as men at taverns or taxi ranks, adolescents at high schools, MSM 
and commercial sex workers.  
 
In order to improve service provision, Bekker (2008) suggests risk stratification and retesting. 
She also emphasises quality training of young people as counsellors or risk reduction experts, 
who are able to discern whether a person should come back in three months, six months or a 
year, based on their level of risk. For example, people in a monogamous relationship who 
have both been tested and are both negative could be told to return for testing within one year; 
a person with a number of partners a week, who is not particularly concerned about condoms, 
might be advised to return in two months. 
 
Bekker (2008) criticises inadequate training of VCT pre- and post-test counsellors, consisting 
of a mere ten-day course and then little checking on quality or skills, with the reality of a huge 
burden of telling someone that they are HIV-positive. She believes risk-reduction counselling 
is not being done well at all. What is needed is a more intensive programme of counselling, 
with risk-reduction experts or specialists asking the important, intimate questions about risk, 
and trying to keep people HIV-negative. 
 
The DTHF will be evaluating the Tutu Tester and its suitability for replication in other 
communities and contexts. The financial cost of such a service would have to be reviewed 
when considering whether it could be replicated elsewhere. Bekker (2008) acknowledges SA 




I have observed VCT drives during my tenure of employment at UCT in a unit tasked with 
providing an institutional response to the HIV epidemic. As distinct from permanent VCT 
sites, they last a day or more at a temporary location within a workplace or other setting. UCT 
utilises a central venue on its main campus. This testing approach results in far greater 











Take for example, Student Wellness Service (SWS) at UCT in SA, which provides VCT at a 
permanent site and at VCT drives on campus. Provision of testing enables the institution to 
identify PLWHA and afford them the appropriate provision in terms of support and care.  
The SWS records attendance at its various facilities. The difference in attendance between 
VCT site provision and drives is stark. With VCT by appointment, 1,166 students tested in 
year 2005 and 985 students in 2006. However, when VCT drives were initiated by SWS on 
the Upper Campus of UCT, over two days in September 2006, 1,052 people tested (637 
females and 415 males). In March 2007, over five days, 2,472 students and 58 staff tested. Of 
these, 1,462 people had tested previously. In August 2007, over three days, 1,329 students and 
46 staff tested for HIV. When the drive was taken to the Medical Campus over five days in 
August 2007, 496 students and 34 staff tested. 
 
Of 1,003 respondents questioned on the VCT drives, 95 percent saw the benefit of HIV testing 
on the upper campus, and 93 percent saw the benefit of testing on all campuses. Seventy-eight 
percent preferred a drop-in system to an appointment system. When asked if and where they 
had tested before, the response was 61 percent on upper campus and only 38.9 percent at the 
permanent site. 
 
Further feedback suggested that students and staff came to the drive because it was 
“convenient”, “accessible” and “quick”, people could go for counselling as a group, and it was 
“professionally conducted”. Service users appreciated the flexibility of being able to leave the 
venue after testing and then being able to return at their convenience for their results. 
Interestingly, few academic staff utilised the facility, perhaps as it did not afford them the 
privacy they preferred (a distancing from the student populace), or because they did not 
consider the facility to be convenient. Also, results were mostly HIV-negative, suggesting 
those who went for testing were not the most at risk. 
 
Resources and skills infrastructure 
 
The problem of resource constraints was tackled in interview. The literature largely applauds 
Botswana‟s success in treatment provision, despite resource constraints. Yet in a much larger 
SA there are constraints of skills and infrastructure that militate against an effective response, 
particularly among rural populations (Butler, 2009). Maartens (2007) describes serious 












although he singles out Gauteng and Western Cape as more efficient. He asserts that for such 
provinces, with poor management, infrastructure and staff capacity, it is difficult to implement 
something like opt-out testing. He believes that different strategies should be adopted in 
different provinces, as demands dictate.  
 
Grimwood (2007) cautions against the segregation of functions that occurs in VCT testing. 
First, a counsellor talks to the client and then a nurse has to be located in order to perform the 
test, who might be in a different part of the building – the wait could take hours and people 
may leave without testing or receiving their results. Rather, he asserts, the process needs to be 
quick and efficient. Counsellors should be allowed to do the test, with the appropriate 
monitoring and regulation. For this to happen, training and capacity building is required, as 
well as the provision of reliable testing kits, approved by the Medicines Control Council 
(MCC). However, as counsellors are a weak lobby group, such a change would require a 
supportive call from already over-stretched professional clinical staff. Cameron (2007) also 
suggests suitably trained lay counsellors could undertake the functions presently being 
performed by both nurses and counsellors. 
 
An additional difficulty, brought about partly by a lack of resources, is the lack of private 
spaces that would put the client more at ease. Bekker (2008) describes oversubscribed, busy 
clinics, where clients have to arrive early in the day and then wait for hours. She also explains 
that if adolescents encounter a bad experience of prejudice, they will not return to be tested. 
 
So, are resources available for expansion efforts? Cleary (2008) describes VCT as an 
expensive means with which to test people; there are costs of counsellors and nurses and a 
space in which the service needs to be accommodated. Rooms also stand empty for much of 
the time, especially when the service is utilised by low volumes of persons. Cameron (2007) 
argues that as resources are scarce, it is not economically viable to continue in this way with 
pre-counselling, particularly as there is already a significant degree of knowledge. 
 
When questioned on the availability of resources in SA for RHT, Cleary (2008) states that 
there are massive amounts of funds in the country (from PEPFAR, etc) that are not being 
spent. Money could be made available, but more healthcare workers would need to be trained 
and employed and healthcare facilities would need to be upgraded. Resources must not be 












burden. Cleary suggests RHT might be cheaper per unit, but scale-up would naturally cost 
more. Bekker (2008) adds that funding should not be an issue, as testing is necessary in order 


















Testing for HIV is a vital component of a complete secondary prevention and treatment 
response to the epidemic in SA. Particularly as ARVs are increasingly available, early testing 
allows for those previously ignorant of their status to benefit from an early diagnosis, in order 
for the correct response to be instituted in terms of personal behaviour, appropriate care and 
the provision of treatment. It is also a cost-effective response, if illness and hospitalisation can 
be avoided. 
 
There is concern, however, among clinicians, health practitioners and other commentators that 
the key testing approach of VCT is not working in SA. As numbers testing are low, 
insufficient persons are identified as being HIV-positive before they become ill with OIs and 
have to be hospitalised. Venter (HIV & AIDS Treatment in Practice, 2007) pulls no punches 
when articulating his frustration: “I hope there‟s a middle road. But all I‟m hearing is, let‟s do 
more. Einstein said the definition of insanity is when you do the same thing over and over 
again and expect a different result”. 
 
Glick (2005) points to the limitations of VCT evaluations to date, such as reliance on self-
reports of behaviour, short follow-up periods, narrow outcome measures, the effect of 
treatment, aspects of the counselling process and unrepresentative study groups. Arguing that 
evaluations have failed to concern themselves with outcomes or effectiveness, Glick (2005) 
suggests “existing evaluations of VCT efficacy do not indicate either potential uptake of VCT 
or how behavioural responses to the programme might change as coverage extends”…. “as 
such, the implications for expanding the coverage of the program to a broader share of the 
target population are not clear”. HIV & AIDS Treatment in Practice (2007) suggests RHT and 
VCT should be compared, as “at present there is little to no comparative data to guide policy”. 
 
Some commentators do not see VCT in itself to have failed, rather blaming inadequate 
implementation. Sedio (Kaisernetwork.org, 2006) questions why the government could not 
have instead increased VCT across the country in tandem with support structures of quality 
counselling and testing provided by civil society organisations. Creek et al. (2007) 












introduction of RHT, once the government committed to ARV rollout and increased public 
education around HIV. Human Rights Watch (2007) argues if opt-in testing is encouraged 
through more aggressive marketing, promotion by healthcare providers and ensuring access to 
ARVs, uptake would improve. HIV & AIDS Treatment in Practice (2007) acknowledges 
governments and funders need to make successful VCT programmes “more accessible and to 
increase public awareness of the need (and personal responsibility) to come in for testing”. 
 
A number of commentators argue for a move from the polarised VCT versus RHT debate. 
Sofia Gruskin27 (2005; 2006) asserts that “It‟s time for the debate to be re-centred onto 
something that actually moves us forward towards sound public health and human rights 
practices, and away from framing these as divergent and even antagonistic concepts”. Mark 
Heywood (2006) states that “human rights and public health should not be at odds”. He argues it 
is a governmental duty to improve the capacity of the health service, enabling RHT whilst also 
observing human rights, improving access to facilities, and reducing the stigma and fear of 
knowing one‟s status. Van Rooyen (2007) indicates that current strategies must be reviewed 
and urges us to move beyond debate and “artificial polarisation”, as insufficient people know 
their status and the testing response needs to be expanded to include client and provider-
initiated models. 
 
The preamble to the third SA AIDS Conference Declaration document (2007) states, “The 
polarisation between client-initiated and provider-initiated counselling and testing is not 
helpful and may hamper the achievement of objectives of the NSP”. Affirming its 
commitment to the NSP, which “provides a plan for… expanding access to HIV… treatment”, 
with HIV testing strategies, it speaks of the need for “dramatic expansion in the accessibility, 
availability and utilisation of counselling and testing services”. The NSP focuses on making 
VCT available and accessible (“for vulnerable groups”), training more personnel, expanding 
the services and “integrating them into community-based, non-medical and outreach service 
settings that are appropriately linked to ongoing prevention, treatment and care services”. 
Point (b) in the document speaks of “aligning the revised national policy on HIV counselling 
and testing with the NSP and WHO guidelines”. 
 
So, there is clearly a consensus regarding the need to “drastically” expand HIV testing 
(Richter, 2006) and commentators propose a combination of interventions. Glick (2005) 












and the cost, in terms of finances and personnel, of each: comparing, for example, in-home 
counselling services, mobile testing, community-based services, standard healthcare setting 
services, RHT and mandatory testing. Such an evaluation would usefully assess the cost-
effectiveness of each service delivery model. 
 
Richter (2006) proposes that “other models” - such as opt-out testing - should complement and 
not replace VCT, which still has an important place, particularly in innovative forms, such as 
mobile clinics and testing incentives. Stegling (2004) also asserts that it is possible to look at 
VCT and other models of VCT, whilst pursuing a routine offer, where the client can refuse 
and make their needs known. Cameron (2007) also suggests that VCT should remain, despite 
its failings, with RHT being introduced in a parallel process in other settings.  
 
UNAIDS (2006) also acknowledges the important contribution made by VCT, which has been 
in existence since 1985, but argue “a more diverse range of approaches is needed to increase 
knowledge of HIV status”… to include VCT (client-initiated) and a provider-initiated 
approach. De Cock (2006) and WHO/UNAIDS (2007) emphasise diversity – a place for both 
client- and provider-initiated testing. 
 
According to Creek et al. (2007), “…the Botswana data provide encouragement that 
successful paradigm shifts can be made even in programs that have long been bound to VCT 
methodologies”. RHT programmes have been favourably reviewed in Botswana and 
elsewhere and Wanyenze et al. (2008) assert that they should be “an integral component of 
any expansion in HIV prevention, care and treatment services in Africa and other areas where 
the prevalence of HIV is high”. However, Denison et al (2008) indicate that the new and 
rapidly expanding approach of provider-initiated testing and counselling has not yet been 
comprehensively evaluated, and that there is a need for the same, particularly regarding its 
impact on behavioural outcomes. Where it is already utilised in SA healthcare settings, with 
pregnant women, TB patients and increasingly persons with STIs, its cost-effectiveness must 
be investigated in the context of an overburdened healthcare system, where resources would 
have to be reallocated, staff trained and a population sensitised.  
 
Other approaches also need to be further researched in order for us to understand their 
efficacy. This would include the mandatory approach that would be difficult to implement in 












insufficiently researched at this time, but could be a viable option in rural districts in 
particular. There would have to be effective support structures in place to manage the (true or 
false) HIV test results, in order to mitigate against the risk of depression and even suicide. 
Testing at home by lay healthworkers and also home self testing (like pregnancy testing) merit 
further research.  
 
VCT drives generally provide easy accessibility to the testing site, which tends to increase 
uptake. The mobile testing approach, like that tried by the DTHF in SA with a personal risk 
assessment, is an effective method to reach communities and can target particular groups 
perceived to be high risk. Immediate CD4 cell count measurement allows immediate access to 
the appropriate medical care. However, this is a high-cost measure that would have to be fully 
evaluated to measure whether it is replicable. Additionally, a lot can also be learned from the 
efforts of the business sector, and private-public partnerships, of bringing wellness drives to 
SA workplaces. It brings a handful of tests to the client, and its convenience, coupled with 
normalisation of the HIV test, has made it an effective testing method. 
 
A need to scale-up is agreed, but should testing be targeted? High-risk groups, particularly 
pregnant women, persons with TB and STIs (generally tested when they seek healthcare 
provision), and also sub-groups such as truck drivers and MSM, are singled out for special 
attention by a number of commentators. Marks et al. (2005) suggest a combination of targeted 
HIV testing campaigns (for MSM) and broad-based screening campaigns will be needed to 
increase people‟s knowledge of their HIV serostatus. Van Rooyen (2007) also articulates the 
need for a variety of testing models that address context and specific target groups, and 
emphasise the voluntary, informed and confidential aspects. Acknowledging that HIV and 
AIDS is a human rights issue, she indicates that we must “create a social environment that 
encourages many more people to test voluntarily for HIV and, when necessary, to seek and 
receive medical treatment and social support”. 
 
The TAC (2009) argues that there is a need for a government campaign to promote testing for 
pregnant mothers, and that the government should “also plan scale-up strategies for testing 
and treatment of children and their fathers”. Gruskin et al. (2008) state there has been 
insufficient documentation of strategies that are working towards achieving a scale-up of 
testing for pregnant women. Kass (2000) concludes that the decline in the rate of HIV 












serve to assist the targeting of all pregnant women who have wanted to test but have not been 
offered one, and that a new approach “reflects a commitment to the poor and minority women 
who have been targeted inappropriately”. 
 
Bartlett (Bartlett & Mayer, 2006) suggests those at high risk should test more than once 
annually, and frequently retest. Bekker (2008) agrees with this risk stratification approach that 
is a component of the integrated DTHF mobile testing response. Mobile testing facilities are 
also useful for truck drivers, despite the difficulty of follow up care provision (Alcorn & 
Smart, 2006) and for women wanting to test without their partners knowing (Morin et al., 
2006). Door-to-door testing has also been found to have high rates of testing acceptance 
(Alcorn & Smart, 2006). 
 
Men in particular, and those who consider themselves to be at low risk, do not test for HIV. 
Recognising this, the NSP addresses “implementing a variety of models to increase 
counselling and testing uptake, with particular emphasis on the youth and men, and non-
reproductive health service users” (p4, point (f)).  
 
Médecins Sans Frontières (2006) recognises people only test once they are sick, as a 
motivation is needed to go for a test. The positives of testing should therefore be emphasized. 
Confidentiality must be guaranteed and private practitioners should be utilized. They suggest a 
few places where testing could be encouraged; blood donation, marriage preparation, visas, 
insurance, childcare pay-points, mobile testing to schools, pre-circumcision testing, testing 
days, role models who test, the workplace and community events. 
 
Effective implementation of any testing method is crucial to its success. With this in mind, a 
“minimum package” is suggested by Gruskin et al. (2008) to accompany RHT, including 
condom and treatment availability, laws and policies that encourage best practice and testing 
uptake, and an infrastructure that allows for appropriate prevention, treatment and care; 
acknowledgement is made of the challenge in providing essential training with RHT roll-out, 
when health services are already overstretched. 
 
For any new approach to work, it is important to increase capacity through sufficient funding 
provision and training. Alcorn & Smart (2006) cite Management Sciences for Health‟s (MSH) 












staff had to be mentored and coached on a monthly basis, and “champions” had to be 
identified to drive the process. Richter (2006) emphasises that “a new testing model should 
require a strong emphasis on (re)training of medical practitioners”. There is a lack of health 
workers to cope with the added pressures of RHT (Cheng, 2007), but Gruskin et al. (2008) 
suggest that staff who would previously have conducted VCT would now be available to 
provide ARVs to the increasing numbers of PLWHA. 
 
Bassett et al. (2007) suggest that the team of dedicated counselling staff available for their 
study may not be available at many public health facilities in SA. In resource-limited settings, 
indicates HIV & AIDS Treatment in Practice (2007), counsellors frequently lack sufficient 
training or remuneration, and quality assurance is not guaranteed. The inadequate provision of 
training in SA is criticised by Venter (HIV & AIDS Treatment in Practice, 2007), who 
suggests the three-day training of counsellors, “seen as cheap labour”, is inadequate, as “now 
they must deal with people‟s fertility issues and issues around stigma, which highly trained 
psychologists can‟t deal with”. Heywood (2005) motivates for the training of community 
health workers as counsellors to ensure informed consent, and greater government leadership 
in the form of availability of health information on treatment literacy and HIV in general. 
 
The need for a holistic approach cannot be overestimated, as testing alone will not drive down 
the epidemic. Cost-effective programmes must be improved, including mass-media education 
campaigns, efforts to make condoms more widely available, and interventions to change high-
risk behaviours (Frieden et al., 2005). Consistent application of proven strategies is required, 
such as syringe exchange, widespread condom distribution, testing expansion, notification of 
partners and medicalisation of the response to the epidemic. These proven interventions could 
prevent many new infections.  
 
Controlling epidemics is a fundamental responsibility of the government, acting in concert 
with physicians, patients and communities. There is a delicate balance between protecting the 
public and the individual right to privacy. For any approach to succeed there needs to be a 
demonstration of government leadership, by committing financial resources and training staff 
appropriately. Frailties of the healthcare system are a concern in any discussion about the 
reenergising of a testing response, in order for more people to be tested. A genuine 
commitment would be needed from leadership in terms of destigmatising HIV and allocating 












partnership developing between civil society and government, fresh initiatives and further 
strides look more likely than ever before, which will go a long way towards normalising a 
chronic, manageable condition and making people comfortable with knowing their status. 
 
The exceptional nature of HIV has to end and offering testing to people in a variety of settings 
will help to achieve this goal, with screening viewed like other lifestyle diseases. Most 
importantly, there must be “synergy between medical ethics, clinical, public health and human 
rights objectives” (WHO, 2007). There is no room for prolonged and polarised debates 
involving human rights and the public good, or for complacency, as we learn honestly from 
our failures and give room to expansion of HIV testing, with a comprehensive response that 
includes the routine or opt-out approach. A scale-up is clearly required of a more 
comprehensive package of testing for HIV, in recognition of the limitations to the VCT 
approach, together with a concerted effort to provide parallel prevention efforts (including 
education campaigns around concurrent relationships and male circumcision) and the 




 Testing for HIV must be promoted as a necessary component of a secondary prevention 
response, together with efforts to destigmatise the virus and the testing process, which will 
serve to reduce gender-based discrimination and violence. 
 
 If the argument presented in this thesis is correct, VCT is not the most effective means by 
which to test for HIV. Where this approach continues to be utilised, there is a need for re-
training of personnel (allowing for task-shifting so that counsellors may perform both the 
test and counselling), the provision of safe spaces in which to test, and greater accessibility, 
for example by increasing VCT drives and mobile testing. 
 
 The research has emphasised the urgent need to scale-up testing for HIV. For this to 
happen, ARV availability must be ensured and health infrastructure improved, without 
necessitating the reallocation of funds from elsewhere. Political will is necessary to ensure 
the funding of comprehensive testing and a rapid ARV roll-out. 
 












legal safeguards. This would entail an injection of resources for appropriate training of 
health professionals (including counsellors to assume testing functions), which would help 
ensure persons are made aware of the importance of testing, symptoms are recognised, the 
right to decline is emphasised and appropriate follow-up support and treatment is provided.  
 
 RHT should be utilised without extensive pre-test counselling, most particularly in the 
contexts of PMTCT, STIs and TB. For this to happen, healthcare facilities would have to be 
improved, and be more effectively utilised, ensuring privacy and safe and confidential 
spaces. The substitution of a special HIV testing facility with integration of the testing 
process into normal health practice (with fully integrated post-test counselling) would serve 
to counter stigma. A public awareness campaign would be necessitated explaining the 
focus on a new approach and how to access linkages to care, and this approach would 
require a comprehensive evaluation. 
 
 Testing should also be made easier for healthy men, and married and older women whose 
perception of risk is low, who would be less likely to visit healthcare providers where RHT 
would be available (thus the necessity to combine approaches to testing). These groups 
might respond better to wellness screening or mobile testing. 
 
 Mobile clinics should offer a range of health services, including (for example) screening for 
diabetes and obesity. This would help to normalise the service. Follow-up should be 
immediate if a person is HIV-positive, with the provision of a CD4 cell count if resources 
are available. Risk-stratification would encourage important re-testing. Additional costs 
may be offset against reduced hospital attendance. Before any method is to be replicated, 
there is need for more research into cost-effectiveness, public perceptions and efficacy.  
 
 Other prevention strategies, such as public education concerning multiple and concurrent 
partners, also need to be scaled up in a way that is holistic and complementary to an 
effective HIV testing response. 
 
 Effective implementation of any testing method is crucial to its success, and it should be 
incorporated into a „package‟ of condom and treatment availability, laws and policies and an 
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